Download to read the full chapter text
Chapter PDF
Literatur
Mollison PL, Engelfriet CP (1993) Blood transfusion in clinical medicine. Blackwell Scientific Publications, London
Müller TH, Hallensleben M, Schunter F, Blasczyk R (2001) Molekulargenetische Blutgruppendiagnostik. Deutsches Ärzteblatt 98: B267–B272
Mueller-Eckhardt C, Kiefel V (2003) Transfusionsmedizin. Springer,Berlin Heidelberg New York
Gesetz zur Regelung des Transfusionswesens (Transfusionsgesetz)– TFG (2007) Bundesgesetzblatt I S. 2169
Bundesärztekammer (2005) Richtlinien zur Gewinnung von Blut und Blutbestandteilen und zur Anwendung von Blutprodukten (Hämotherapie),Aufgestellt gemäß Transfusionsgesetz von der Bundesärztekammer im Einvernehmen mit dem Paul-Ehrlich-Institut, Gesamtnovelle 2005, Deutscher Ärzteverlag, Köln
Vorstand und Wissenschaftlicher Beirat der Bundesärztekammer (2003) (Hrsg) Leitlinien zur Therapie mit Blutkomponenten und Plasmaderivaten. 3. Aufl. Deutscher Ärzte-Verlag, Köln
Metaxas-Bühler M (1995) Blutgruppen und Transfusion. 2. Aufl. Verlag Hans Huber, Bern
Mueller-Eckhardt C, Kiefel V (2004) (Hrsg) Transfusionsmedizin: Grundlagen – Therapie – Methodik. 3. Aufl. Springer, Berlin Heidelberg New York
Klein HG, Anstee DJ (2005) Mollison’s. 11th ed. Blood Transfusion in Clinical Medicine, a revision of the 10th editition written by Mollison PL, Engelfriet CP, Contreras M. Blackwell Publishing, London
Falbe J, Regitz M (Hrsg) (1989) Römpp Chemie Lexikon. Georg Thieme Verlag, Stuttgart New York
Abell LL, Levy BB, Brodie BB et al (1951) Simplified methods for the estimation of total cholesterol in serum and demonstration of its specificity. J Biol Chem 195:3573-3566
BIPM, IEC, IFCC, ILAC, ISO, IUPAC, IUPAP, OIML (2010). Internationales Wörterbuch der Metrologie (VIM) Deutsch-englische Fassung. ISO/IEC-Leitfaden 99:2007. 3. Aufl. Beuth-Verlag, Berlin
Rowley JD (1973) Letter: A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia Identified by Quinacrine Fluorescence and Giemsa Staining. Nature 243:290-293
Bartram CR, de Klein A, Hagemeijer A et al (1983) Translocation of c-abl Oncogene Correlates with the Presence of a Philadelphia Chromosome in Chronic Myelocytic Leukaemia. Nature 306:277-280
Hilgers R-D, Bauer P, Scheiber V (2002) Einführung in die Medizinische Statistik. Springer-Verlag, Berlin Heidelberg New York
Giebelmann R (2001) Kulturgeschichtliches zum Thujon. Toxichem Krimtech 48:43-46
Kortüm G (1962) Kolorimetrie, Photometrie und Spektrometrie. Eine Anleitung zur Ausführung von Absorptions-, Emissions-, Fluoreszenz-, Streuungs-, Trübungs- und Reflexionsmessungen. Springer-Verlag, Berlin Göttingen Heidelberg
Zweig MH, Campbell G (1993) Receiver-operating characteristic (ROC) Plots: A fundamental evaluation tool in clinical medicine. Clin Chem 39:561-577
Bowman HS (1963) Red Cell Preservation in Citrate-Phosphate- Dextrose and Acid-Citrate Dextrose. Transfusion 3:364-367
Högman C F, Akerblom O, Hedlund K, Rosen I, Wiklund L (1983) Red cell suspensions in SAGM medium. Vox Sang 45:217-223
Ferguson RA, Goldberg DM (1997) Genetic markers of alcohol abuse. Clin Chim Acta 257:199-250
Gressner AM, Gressner OA (2006) Alkoholabusus – Mittels Ethanol- abhängiger Metabolite erkennen und kontrollieren. Med Welt 57:262-270
Korri UM, Nuutinen H, Salaspuro M (1985) Increased Blood Acetate: A New Laboratory Marker of Alcoholism and Heavy Drinking. Alcoholism: Clin Exp Res 9:468-471
Gressner AM, Gressner OA (2006) Alkoholsabusus-mittels Ethanolabhängiger Metabolite erkennen und kontrollieren. Med Welt 57: 262-270
Kruse-Jarres JD, Reinauer H, Witt I (1995) Kohlenhydratstoffwechsel. In: Greiling H, Gressner AM (Hrsg) Lehrbuch der Klinischen Chemie und Pathobiochemie. 3. Aufl. Schattauer Verlag, Stuttgart New York
Löffler G, Petrides PE (1997) Biochemie und Pathobiochemie. 5. Aufl. Springer-Verlag, Berlin Heidelberg New York
Friedman S, Fraenkel G (1955) Reversible Enzymatic Acetylation of Carnitine. Arch Biochem Biophys 51:491-501
Gürtler AK, Löster H (1996) Carnitin und seine Bedeutung bei der Pathogenese und Therapie von Herz- und Kreislauferkrankungen. Ponte Press, Bochum
Hilgers R-D, Bauer P, Scheiber V (2002) Einführung in die Medizinische Statistik. Springer-Verlag, Berlin Heidelberg New York
Kurtzman NA (2000) Renal Tubular Acidosis Syndromes. Southern Medical J 93:1042-1052
Swenson ER (2001) Metabolic Acidosis. Respiratory Care 46:342-353
Epstein SK, Singh N (2001) Respiratory Acidosis. Respiratory Care 46 (4):366-383
Mollison PL, Engelfriet CP (1993) Blood transfusion in clinical medicine. Blackwell Scientific Publications, London
Mueller-Eckhardt C, Kiefel V (2003) Transfusionsmedizin. Springer, Berlin Heidelberg New York
Oelkers W (1996) Dose-Response Aspects in the Clinical Assessment of the Hypothalamo-Pituitary-Adrenal Axis, and the Low-Dose Adrenocorticotropin Test. Eur J Endocrin 135:27-33
Schulze A, Lindner M, Kohlmueller D et al (2003) Expanded newborn screening for inborn errors of metabolism by electrospray ionization-tandem mass spectrometry: results, outcome, and implications. Pediatrics 111:1399-1406
Addis T (1926) The Number of Formed Elements in the Urinary Sediment of Normal Individuals. J Clin Invest 2:409-421
Falbe J, Regitz M (Hrsg) (1989) Römpp Chemie Lexikon. Georg Thieme Verlag, Stuttgart New York
Kuhara T (2002) Diagnosis and monitoring of inborn errors of metabolism using urease-pretreatment of urine, isotope dilution, and gas chromatography mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 781:497-517
Apasov SG, Blackburn MR, Kellems RE et al (2001) Adenosine deaminase deficiency increases thymic apoptosis and causes defective T cell receptor signalling. J Clin Invest 108:131-141
Hershfield MS, Mitchell BS (1995) Immunodeficiency diseases caused by adenosine deaminase deficiency and purine phosphorylase deficiency. In: Scriver CR, Beaudet AL, Sly WS et al (eds) The molecular and metabolic basis of inherited disease. McGraw-Hill, NewYork, pp 1725-1768
Carlucci F, Tabucchi A, Aiuti A et al (2003) Capillary electrophoresis in diagnosis and monitoring of adenosine deaminase deficiency. Clin Chem 49:1830-1838
Gachet C (2008) P2 receptors, platelet function and pharmacological implications. Thromb Haemost 99: 466-472
Langley JM (2005) Adenoviruses. Pediatr Rev 26(7):244-249
Handermann M (2009) Adenoviren. In: Darai G, Handermann M, Sonntag HG, Tidona CA, Zöller L (Hrsg) Lexikon der Infektionskrankheiten des Menschen, 3. Aufl. Springer-Verlag, Heidelberg Berlin New York S. 6-11
Hoffman JA (2009) Adenovirus infections in solid organ transplant recipients. Curr Opin Organ Transplant 14(6):625-633
Johnson JP (1999) Cell adhesion molecules in the development and progression of malignant melanoma. Cancer Metast Rev 18:345-357
Meier U, Gressner AM (2004) Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin and resistin. Clin Chem 50:1511-1525
Meier U, Gressner M (2004) Endocrine Regulation of Energy Metabolism: Review of Pathobiochemical and Clinical Chemical Aspects of Leptin, Ghrelin, Adiponectin, and Resistin. Clin Chem 50:1511-1525
Talbot JA, Kane JW, White A (2003) Analytical and clinical aspects of adrenocorticotropin determinations. Ann Clin Biochem 40:453-471
Hinson JP, Kapas S, Smith DM (2000) Adrenomedullin, a multifunctional regulatory peptide. Endocrine Reviews 21:138-167
Cuttitta F, Martinez A (1997) Adrenomedullin. IOS Press, The Netherlands
Latscha HP, Linti GW, Klein HA (2004) Analytische Chemie. Chemie-Basiswissen III. Springer-Verlag, Berlin Heidelberg NewYork
American Association of Blood Banks (1999) Technical Manual 13th edition, S. Karger, Basel
Brownlee M (1995) Advanced protein glycosylation in diabetes and aging. Annu Rev Med 46:223-234
Singh R, Barden A, Mori T et al (2001) Advanced glycation end-products: a review. Diabetologia 44:129-146
Löffler G, Petrides PE (1997) Biochemie und Pathobiochemie, 5. Aufl. Springer, Heidelberg Berlin New York
Unger KK (Hrsg) (1989) Handbuch der HPLC. Teil 1 Leitfaden für Anfänger und Praktiker. GIT Verlag, Darmstadt
The MERCK Index (2006) 15. Aufl. MERCK Co., Inc. Whitehouse Station, NJ, USA
Shimura K, Kasai K (1987) Affinophoresis in two-dimensional agarose gel electrophoresis: specific separation of biomolecules by a moving affinity ligand. Anal Biochem 116:200-206
Ogden RC, Adams DA (1987) Electrophoresis in agarose and acrylamide gels. Meth Enzymol 152:61-87
Le Carrer D (1994) Elektrophorese & Immunfixation von Proteinen. Die Interpretation von Versuchsergebnissen mit zahlreichen Trennbeispielen. SA Sebia, Paris
Martin R (1996) Elektrophorese von Nucleinsäuren. Spektrum Akademischer Verlag, Heidelberg
Mueller-Eckhardt C, Kiefel V (Hrsg) (2004) Transfusionsmedizin:Grundlagen – Therapie – Methodik. 3. Auflage, Springer Berlin Heidelberg New York
Eckstein R (2005) Immunhämatologie und Transfusionsmedizin, 5. Auflage, Gustav Fischer, Stuttgart
Berzofsky JA, Epstein SL, Berkower IJ (1989) Antigenantibody interactions and monoclonal antibodies. In: Paul WA (ed) undamental Immunology. 2nd edn. Raven Press, New York
Kiani C, Chen L, Wu Yj et al (2002) Structure and function of aggrecan. Cell Res 12:19-32
Lark MW, Bayne EK, Flanagan J et al (1997) Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthrotic, and rheumatoid joints. J Clin Invest 100:93-106
Fischer DC, Kolbe-Busch S, Stöcker G et al (1994) Development of enzyme immuno assays for keratan sulphate- and core-protein epitopes of the large aggregating proteoglycan from human articular cartilage. Eur J Clin Clin Biochem 32:285-291
Malfait AM, Lui RQ, Ijiri K et al (2002) Inhibition of ADAM-TS4 and ADAM-TS5 prevents aggrecan degradation in osteoarthritic cartilage. J Biol Chem 277:2201-2208
Lark MW, Bayne EK, Flanagan J et al (1997) Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthrotic, and rheumatoid joints. J Clin Invest 100:93-106
Moll J, Barzaghi P, Lin S, Bezakova G, Lochmuller H, Engvall E, Muller U, Ruegg MA (2001) An agrin minigene rescues dystrophic symptoms in a mouse model for congenital muscular dystrophy. Nature 413:302-307
Raats CJ, Bakker MA, Hoch W, Tamboer WP, Groffen AJ, Van Den Heuvel LP, Berden JH, Van Den Born J (1998) Differential expression of agrin in renal basement membranes as revealed by domain-specific antibodies. J Biol Chem 273:17832-17838
Schütz E, Schaefer RM, Heidbreder E et al (1985) Effect of diuresis on urinary erythrocyte morphology in glomerulonephritis. Klin Wchschr 63:575-577
Köhler H, Wandel E, Brunck B (1991) Acanthocyturia – a characteristic marker of glomerular bleeding. Kidney Int 40:115-120
DIN EN ISO/IEC 17000:2005 „Konformitätsbewertung – Begriffe und allgemeine Grundlagen“
DIN EN ISO/IEC 17011:2005 „Allgemeine Anforderungen an Akkreditierungsstellen, die Konformitätsbewertungsstellen akkreditieren“
Gabay C, Kushner I (1999) Acute-Phase Proteins and other systemic responses to inflammation. N Engl J Med 340:448-454
Gressner AM, Thomas L (1995) Proteinstoffwechsel. In: Greiling H, Gressner AM (Hrsg) Lehrbuch der Klinischen Chemie und Pathobiochemie, 3. Aufl. Schattauer-Verlag, Stuttgart, S 194-246
Bull BS et al (1988) Guidelines on selection of laboratory tests for monitoring the acute phase response. J Clin Pathol 41:1203-1212
Duran M (2008) Amino acids. In: Blau N, Duran M, Gibson KM (eds) Laboratory Guide to the Methods in Biochemical Genetics. Springer, Heidelberg, Berlin, New York pp 53-90
Haas RH, Parikh A, Falk MJ et al (2008) The in-depth evaluation of ksuspected mitochondrial disease. Mol Genet Metab 94:16-37
Doumas BT, Peters T Jr (1997) Serum and urine albumin: a progress report on their measurement and clinical significance. Clin Chim Acta 258:3-20
Quinlan G J, Martin G S, Evans T W (2005) Albumin: Biochemical properties and therapeutic potential. Hepatology 41:1211-1219
Arroyo V (2009) Human serum albumin: Not just a plasma volume expander. Hepatology 50:355-357
Hasslacher C, Wolf G, Kampe P, Ritz E (2008) Diabetische Nephropathie. In: Praxisleitlinien der Deutschen Diabetes-Gesellschaft. Diabetol 3, Suppl 2:S143–146
Hofmann W, Ehrich JHH, Guder WG, Keller F, Scherberich JE (2011) Diagnostische Pfade bei Nierenerkrankungen. Nieren- und ochdruckkrankheiten 40:47-70
Osicka TM, Comper WD (2004) Characterization of Immunochemically Nonreactive Urinary Albumin. Clin Chem 50:2286-2291
Schena FP (1994) Domenico Cotugno and his interest in Proteinuria. Am J Nephrol 14:325-329
Alder A (1939) Über konstitutionell bedingte Granulationsveränderungen der Leukocyten. Dtsch Arch Klin Med 183:372-378
Löffler H, Rastetter J (1999) Atlas der klinischen Hämatologie. 5. Aufl. Springer-Verlag, Berlin Heidelberg New York, S 44-46
Ali M, Rellos P, Cox TM (1998) Hereditary fructose intolerance. J Med Genet 35:353-365
Hubl W, Thomas L (2005) Renin-Angiotensin-Aldosteron- System. In: Thomas L (Hrsg) Labor und Diagnose. 6. Aufl. TH-Books, Frankfurt/Main, S 1406-1424
Abdelhamid S, Blomer R, Hommel G et al (2003) Urinary tetrahydroaldosterone as a screening method for primary aldosteronism: a comparative study. Am J Hypertens 16:522-530
Perschel FH, Schemer R, Seiler L et al (2004) Rapid Screening Test for Primary Hyperaldosteronism: Ratio of Plasma Aldosterone to Renin Concentration Determined by Fully Automated Chemiluminescence Immunoassays. Clin Chem 50:1650-1655
Schwartz GL, Chapman AB, Boerwinkle E et al (2002) Screening for primary aldosteronism: Implications of an increased plasma aldosterone/ renin ratio. Clin Chem 48:1919-1923
Huber H, Pastner D, Gabl F (1972) Laboratoriumsdiagnose hämatologischer und immunologischer Erkrankungen. Springer- Verlag, Berlin Heidelberg New York, S 216-218
Peters JP, van Slyke DD (1932) Quantitative Clinical Chemistry. II. Methods. 1st edn. Williams and Wilkins, Baltimore
Meifsner* W (1819) Ueber ein neues Pflanzenalkali (Alkaloid). J Chem Phys; XXV:377-381 (*neue Schreibweise Meißner, auch Meissner)
Moss GP, Smith PAS, Tavernier D (1995) Glossary of class names of organic compounds and reactivity intermediates based on structure (IUPAC Recommendations 1995) Pure & Appl Chem 67:1313
Teuscher E, Lindequist U (2010) Biogene Gifte. Biologie – Chemie – Pharmakologie – Toxikologie. 3. Auflage, Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart
Grobe N (2009) Biosynthesis of Morphins in Mammals. Dissertation, Naturwissenschaftliche Fakultät I, Biowissenschaften, Martin-Luther- Universität Halle (http://digital.bibliothek.uni-halle.de/hs/content/titleinfo/411034;Stand:28.September2011 )
Khanna A, Kurtzman NA (2001) Metabolic Alkalosis. Respiratory Care 46:354-365
Foster GT, Vaziri ND, Sassoons CS (2001) Respiratory Alkalosis. Respiratory Care 46:384-391
Guder WG, Narayanan S, Wisser H Zawta B (2009) Diagnostic Samples: From the Patient to the Laboratory. 4th ed. Wiley- Blackwell, Weinheim
Young DS (2007) Effects of Preanalytical Variables on Clinical Laboratory Tests. 3rd edn. AACC Press, Washington DC
Zintzaras E, Stefanidis I, Santos M, Vidal F (2006) Do Alcohol-Metabolizing Enzyme Gene Polymorphisms Increase the Risk of Alcoholism and Alcoholic Liver Disease? Hepatology 43:352-361
Arndt T, Gressner AM, Kropf J (1994) Labordiagnostik und Kontrolle des Alkoholabusus – ein Plädoyer für Carbohydrate- Deficient-Transferrin (CDT). medwelt 45:247-257
Arndt T (2011) Biomarker des Alkoholkonsums – Eine Übersicht. Toxichem Krimtech 78:419-430
Thomas L (Hrsg) (2008) Labor und Diagnose. 7. Aufl. Frankfurt/Main, S 1120f
Eckstein R (2005) Immunhämatologie und Transfusionsmedizin. Urban & Fischer, München
Mueller-Eckhardt C, Kiefel V (2003) Transfusionsmedizin. Springer, Berlin Heidelberg New York
EcksteiImmunhämatologie und Transfusionsmedizinn R (2005) Immunhämatologie und Transfusionsmedizin. Urban & Fischer, München Mueller
Eckhardt C, Kiefel V (2003) Transfusionsmedizin. Springer, Berlin Heidelberg New York
Bremer HJ, Duran M, Kamerling JP et al (1981) Disturbances of Aminoacid Metabolism: Clinical Chemistry and Diagnosis. Urban & Schwarzenberg, Munich and Baltimore
Duran M (2008) Amino acids. In: Blau N, Duran M, Gibson KM (eds) Laboratory Guide to the Methods in Biochemical Genetics, Springer, Heidelberg Berlin New York pp 53-90
Hafner L, Hoff P (1977) Genetik. Hermann Schroedel Verlag, Hannover Dortmund Darmstadt Berlin
Hallmann L, Burkhardt F (1974) Klinische Mikrobiologie. 4. Aufl. Georg Thieme Verlag, Stuttgart New York
Hilgers RD, Bauer P, Scheiber V (2002) Einführung in die Medizinische Statistik. Springer-Verlag, Berlin Heidelberg New York
Elsenhans B (2002) Aluminium. In: Biesalski HK, Köhrle J, Schümann K (Hrsg) Vitamine, Spurenelemente und Mineralstoffe. Georg Thieme Verlag, Stuttgart New York, S 227-231
Kazazian HH Jr (2004) Mobile Elements: Drivers of Genome Evolution. Science 303:1626-1632
Iizuka M, Mashiyama S, Oshimura M et al (1992) Cloning and Polymerase Chain Reation-Single-Strand Conformation Polymorphism Analysis of Anonimous Alu Repeats on Chromosome 11. Genomics 12:139-146
Löffler G, Petrides PE (1997) Biochemie und Pathobiochemie. 5. Aufl. Springer-Verlag, Berlin Heidelberg New York
Degel F (2009) Poisonous mushrooms. In: Külpmann WR (ed) Clincial toxicological analysis. Wiley-VCH, Weinheim, pp 809-823
Westermeier R (2004) Electrophoresis in Practice. Wiley-VCH, Weinheim
Ludewig R (1999) Akute Vergiftungen. Wiss. Verlagsgesellschaft, Stuttgart, S 100-102
Bremer HJ, Duran M, Kamerling JP et al (1981) Disturbances of Aminoacid Metabolism: Clinical Chemistry and Diagnosis, Urban & Schwarzenberg, Munich and Baltimore
Sewell AC, Herwig J, Böhles H et al (1999) Normal kynurenine metabolism in 2-oxoadipic aciduria. J Inher Metab Dis 22: 949-950
Bremer HJ, Duran M, Kamerling JP et al (1981) Disturbances of Aminoacid Metabolism: Clinical Chemistry and Diagnosis, Urban & Schwarzenberg, Munich and Baltimore
Jaeken J, Jakobs C, Wevers R (2000) Disorders of Neurotransmission. In: Fernandes J, Saudubray J-M, van den Berghe G (eds) Inborn Metabolic Diseases: Diagnosis and Treatment. 3rd edn. Springer- Verlag, Berlin Heidelberg New York, pp 301-311
Roberts E, Frankel S (1950) Gamma-aminobutyric acid in brain: its formation from glutamic acid. J Biol Chem 187:55-63
Bremer HJ, Duran M, Kamerling JP et al (1981) Disturbances of Aminoacid Metabolism: Clinical Chemistry and Diagnosis, Urban & Schwarzenberg, Munich and Baltimore
Mauzerall D, Granick S (1956) The Occurrence and Determination of δ-Aminolevulinic Acid and Porphobilinogen in Urine. J Biol Chem 219:435-446
Doss MO (2000) Porphyrie. In: Thomas L (Hrsg) Labor und Diagnose. 5. Aufl. TH Books Verlagsgesellschaft mbH, Frankfurt/Main, S 458-474
Bishop DF, Desnick RJ (eds) (1982) Assays of the Heme Biosynthetic Enzymes. Enzyme 28 (2-3):89-232
Doss MO (2000) Porphyrie. In: Thomas L (Hrsg) Labor und Diagnose. Indikation und Bewertung von Laborbefunden für die Medizinische Diagnostik. TH-Books, Frankfurt/Main, S 458-474
Bickers DR, Frank J (2003) The Porphyrias. In: Freedberg IM, Eisen AZ, Wolff K et al (eds) Dermatology in General Medicine. 6th edn. McGraw Hill, New York, pp 1435-1466
Bishop DF, Desnick RJ (eds) (1982) Assays of the Heme Biosynthetic Enzymes. Enzyme 28 (2-3):89-232
Doss MO (2000) Porphyrie. In: Thomas L (Hrsg) Labor und Diagnose. Indikation und Bewertung von Laborbefunden für die Medizinische Diagnostik. TH-Books, Frankfurt/Main, S 458-474
Bickers DR, Frank J (2003) The Porphyrias. In: Freedberg IM, Eisen AZ, Wolff K et al (eds) Dermatology in General Medicine. 6th edn. McGraw Hill, New York, pp 1435-1466
Merkel C, Bolognesi M, Bellon S et al (1992) Aminopyrine Breath Test in the Prognostic Evaluation of Patients with Cirrhosis. Gut 33:836-842
Chernoff R (2004) Protein and older adults. J Am Coll Clin Nutr 23: 627S–630S
Duran M (2008) Amino acids. In: Blau N, Duran M, Gibson KM (eds) Laboratory Guide to the Methods in Biochemical Genetics, Springer, Berlin Heidelberg New York, pp 53-90
Moore S, Spackman DS, Stein WH (1958) Automatic recording device for use in the chromatography of amino acids. Fed Proc 17: 1107-1115
Schulze A, Lindner M, Kohlmueller D, Olgemoeller K, Mayatepek E, Hoffmann GF (2003) Expanded newborn screening for inborn errors of etabolism by electrospray ionization-tandem mass spectrometry: results, outcome, and implications. Pediatrics 111:1399-1406
Clemens JD, Herrick MV, Singer FR et al (1997) Evidence that serum NTx (collagen type I N-telopeptides) can act as an immunochemical marker of bone resorption. Clin Chem 43:2058-2063
Hanson DA, Eyre DR (1996) Molecular site specificity of pyridinoline and pyrrole cross-links in type I collagen of human bone. J Biol Chem 271:26508-26516
Ju H-SJ, Leung S, Brown B et al (1997) Comparison of analytical performance and biological variability of three bone resorption assays. Clin Chem 43:1570-1576
Kanda S, Sudo K, Kanno T (1984) A specific kinetic assay for tripeptide aminopeptidase in serum. Clin Chem 30: 843-846
König H, Schmoldt M (2009) Antidysrhythmic agents. In: Külpmann WR (ed) Clincial toxicological analysis. Wiley-VCH, Weinheim, pp 271-285
Bachmann C (2002) Mechanisms of Hyperammonemia. Clin Chem Lab Med 40:653-662
Häberle J, Koch HG (2004) Hyperammonämie: Ursachen, Diagnostik, Therapie. Dtsch Med Wochenschr 129:1381-1384
Da Fonseca-Wollheim (1973) Direkte Plasmaammoniakbestimmung ohne Enteiweißung. J Clin Chem Clin Biochem 11:426-431
Castell DO (1965) The ammonia tolerance test: An index of portal hypertension. Gastroenterology 49:539-543
Thomas L (Hrsg) (2005) Labor und Diagnose. Indikation und Bewertung von Laborbefunden für die medizinische Diagnostik. TH-Books, Frankfurt/Main
Greiling H, Gressner AM (Hrsg) (1994) Lehrbuch der Klinischen Chemie und Pathobiochemie. 3. Aufl. Schattauer Verlag, Stuttgart New York
Näser K-H, Peschel G (1986) Physikalisch-chemische Meßmethoden. 4. Aufl. Deutscher Verlag für Grundstoffindustrie, Leipzig
Latscha HP, Linti GW, Klein HA (2004) Analytische Chemie. Chemie – Basiswissen III. Springer-Verlag, Berlin Heidelberg New York
Allen RC, Graves G, Budowle (1989) Polymerase Chain Reaction Amplification Products Separated on Rehydratable Polyacrylamide Gels and Stained with Silver. Biotechniques 7:736-744
Budowle B, Chakraborty R, Giusti AM et al (1991) Analysis of the VNTR Locus D1S80 by the PCR Followed by High-Resolution PAGE. Am J Hum Genet 48:841-855
Käferstein H, Sticht G (2009) Amphetamines. In: Külpmann WR (ed) Clincial toxicological analysis. Wiley-VCH, Weinheim, pp 463-470
Zaske D, Cerra FB, Koontz FP (1986) Antibiotics and other anti-infective agents. In: Taylor WJ, Diers Caviness MH (eds) A textbook for the clinical application of therapeutic drug monitoring. Abbott, Irving
Clavé P, Guillaumes S, Blanco I et al (1995) Amylase, Lipase, Pancreatic Isoamylase, and hospholipase A in Diagnosis of Acute Pancreatitis. Clin Chem 41:1129-1134
Junge W, Wortmann W, Wilke B et al (2001) Development and evaluation of assays for the determination of total and pancreatic amylase at 37 °C according to the principle recommended by the IFCC. Clin Biochem 34:607-615
Hull RL, Westermark GT, Westermark P et al (2004) Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes. J Clin Endocrinol Metab 89:3629-3643
Wolfsdorf JI, Weinstein DA (2003) Glycogen storage diseases. Rev Endocr Metab Disord 4:95-102
Schönland SO (2006) Fortschritte in der Diagnostik und Therapie der Amyloidosen. Dtsch Arztebl 103:A2237–A2244
Lachmann HJ, Goodman HJB, Gilbertson JA et al (2007) Natural history and outcome in systemic AA amyloidosis. N Engl J Med 356:2361-2371
Fagan AM, Shaw LM, Xiong Cet al (2011) Comparison of analytical platforms for cerebrospinal fluid measures of β-amyloid 1-42, total tau, and p-tau181 for identifying Alzheimer disease amyloid plaque pathology. Arch Neurol 68:1137-1144
Kim J, Holtzman DM (2010) Prion-like behavior of amyloid-β. Science 330:918-919
Lahiri DK, Maloney B (2010) Beyond the signaling effect role of amyloid-β42 on the processing of APP, and its clinical implications. Exp Neurol 225:51-54
Rösler N, Wichart I, Jellinger KA (2002) Aktuelle klinisch-neurochemische Diagnostik der Alzheimer-Krankheit. J Lab Med 26:139-148
Greiling H, Gressner AM (Hrsg) (1995) Lehrbuch der Klinischen Chemie und Pathobiochemie. Schattauer Verlag, Stuttgart New York
DIN-Norm EN ISO/IEC 17025
GTFCh (2009) Richtlinie der GTFCh zur Qualitätssicherung bei forensisch-toxikologischen Untersuchungen. Toxichem Krimtech 76:142-176
TIAFT (2001) Systematic Toxicological Analysis: Laboratory Guidelines. TIAFT Bulletin XXXI Nr. 4:23-26 oder http://www.tiaft.org/about/sta_laboratory.php,geprüft16.08.2011
Kingston HM, Kingston ML (1994) Nomenclature in laboratory robotics and automation. Pure & Appl Chem 66:609-630
Haeckel R (1995) Rationalisierung quantitativer Analysenverfahren. In: Greiling H, Gressner AM (Hrsg) Lehrbuch der Klinischen Chemie und Pathobiochemie. Schattauer Verlag, Stuttgart New York
Skeggs LT (1957) An automatic method for colorimetric analysis. Am J Clin Path 28:311-322
EN 12286 (1998)
Haeckel R, Fischer G, Fischer M et al (1984) Vorschläge zur Definition von Zeitbegriffen. Dt Ges Klin Chem Mitteilungen 14:187-192
Richtlinie der Bundesärztekammer zur Qualitätssicherung quantitativer laboratoriumsmedizinischer Untersuchungen (2008) Dt Ärzteblatt 105:A3417–A355
Stamm D, Büttner J (1995) Klinisch-chemische Analytik. In: Greiling H, Gressner AM (Hrsg) Lehrbuch der Klinischen Chemie und Pathobiochemie. 3. Aufl. Schattauer Verlag, Stuttgart, S 6-36
Miller KK, Rosner W, Lee H et al (2004) Measurement of Free Testosterone in Normal Women and Women with Androgen Deficiency: Comparison of Methods. J Clin Endocrinol Metab 89:525-533
Miller KK, Rosner W, Lee H et al (2004) Measurement of free testosterone in normal women and women with androgen deficiency: comparison of methods. J Clin Endocrinol Metab 89:525-533
Castracane VD et al (1999) Androgen parameters in hirsute and normal female patients: is there a role for the free androgen index (FAI)? Clin Chem 45:A80
Burger HG (2002) Androgen Production in Women. Fertil Steril 77:3-5
Cavallo A, Corn C, Bryan GT et al (1979) The Use of Plasma Androstenedione in Monitoring Therapy of Patients with Congenital Adrenal Hyperplasia. J Pediatr 95:33-37
Gladtke E, von Hattingberg HM (1973) Pharmakokinetik. Springer-Verlag, Berlin Heidelberg New York
Bunting PS, Szalai JP, Katic M (1987) Diagnostic aspects of angiotensin converting enzyme in pulmonary sarcoidosis. Clin Biochem 20:213-219
Arbustini E, Grasso M, Fasani R, Klersy C, Diegoli M, Porcu E, Banchieri N, Fortina P, Danesino C, Specchia G (1995) Angiotensin converting enzyme gene deletion allele is independently and strongly associated with coronary atherosclerosis and myocardial infarction. Brit Heart J 74:584-591
Mattei M-G, Hubert C, Alhenc-Gelas F, Roeckel N, Corvol P, Soubrier F (1989) Angiotensin-I converting enzyme gene is on chromosome 17. Cytogenet Cell Genet 51:1041
Morimatsu H, Rocktaschel J, Bellomo R et al (2003) Comparison of Point-of-Care versus Central Laboratory Measurement of Electrolyte Concentrations on Calculations of the Anion Gap and the Strong Ion Difference. Anesthesiology 98:1077-1084
Koeppen KM, Heller S (1991) Differenzialblutbild (panoptische Färbung). In: Boll I, Heller S (Hrsg) Praktische Blutzelldiagnostik. Springer-Verlag, Berlin Heidelberg New York, S 170
Hilgers R-D, Bauer P, Scheiber V (2002) Einführung in die Medizinische Statistik. Springer-Verlag, Berlin Heidelberg New York
Falbe J, Regitz M (Hrsg) (1990) Römpp Chemie Lexikon. Georg Thieme Verlag, Stuttgart New York
Bremer HJ, Duran M, Kamerling JP et al (1981) Disturbances of Aminoacid Metabolism: Clinical Chemistry and Diagnosis, Urban & Schwarzenberg, Munich and Baltimore
Gabay C, Kushner I (1999) Acute-Phase Proteins and other systemic responses to inflammation. N Engl J Med 340:448-454
Genné D, Siegrist H (2003) Vom Antibiogramm zur Wahl eines Antibiotikums. Schweiz Med Forum 20:464-468
Mutschler E (2001) Arzneimittelwirkungen. Lehrbuch der Pharmakologie und Toxikologie. Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart
www.mikrobio.med.tu-muenchen.de/diagnose/nachweis/immunreaktion3.html
Zhang S, Janciauskiene S (2002) Multifunctional capability of proteins: α1-antichymotrypsin and the correlation with Alzheimer’s disease. J Alzheimer’s Disease 4:115-122
Degel F, Birkhahn HJ, Demme U et al (2009) Neuroleptic drugs and antidepressants. In: Külpmann WR (ed) Clincial toxicological analysis. Wiley-VCH, Weinheim, pp 393-453
Hallbach J, Rentsch K (2009) Antidiabetics. In: Külpmann WR (ed) Clincial toxicological analysis. Wiley-VCH, Weinheim, pp 613-621
Robertson GL (1994) The Use of Vasopressin Assays in Physiology and Pathophysiology. Semin Nephrol 14:368-383
Robertson GL (2001) Antidiuretic Hormone. Normal and Disordered Function. Endocrinol Metab Clin North Am 30:671-694
Bundesärztekammer (2005) Richtlinien zur Gewinnung von Blut und Blutbestandteilen und zur Anwendung von Blutprodukten (Hämotherapie), Aufgestellt gemäß Transfusionsgesetz von der Bundesärztekammer im Einvernehmen mit dem Paul-Ehrlich- Institut, Gesamtnovelle 2005, Deutscher Ärzteverlag, Köln
Cruise JM, Lewis RE (1999) Atlas of Immunology. Springer-Verlag, Berlin Heidelberg New York
www.mikrobio.med.tu-muenchen.de/diagnose/ nachweis/ immunreaktion3.html
Klein J, Horejsi V (1997) Immunology. 2nd edn. Blackwell Sciences, Oxford, pp 466-468
Thomas L (Hrsg) (2005) Labor und Diagnose. 6. Aufl. THBooks, Frankfurt/Main, S 1918f
Heidelberger M, Kendall FE (1935). A quantitative theory of the precipitin reaction: III. The reaction between crystalline egg albumin and its homologous antibody. J Exp Med 62:697-720
Coombs RRA, Mourant AE, Race RR (1945) A new test for the detection of weak and „incomplete Rh agglutinins“. Br J Exp Pathol 26: 255-266
Bihoreau N et al (1994) Copper-atom identification in the active and inactive forms of plasma-derivided FVIII and recombinant FVIII-delta II. Eur Biochem 222:41-48
Rosenblum WI (1968) In vitro measurements of the effects of anticoagulants on the flow properties of blood: the relationship of these effects to red cell shrinkage. Blood 31:234-241
CLSI Document H1-A6 (2010) Tubes and additives for venous and capillary blood specimen collection; approved standard EN/DIN 14820 (2004) Gefäße zur einmaligen Verwendung für die venöse Blutabnahme beim Menschen. Beuth-Verlag, Berlin
Immunglobulin-Subklassen
Köhler G, Milstein C (1975) Continuous Cultures of Fused Cells Secreting Antibody of Predefined Specificity. Nature 256, 495-497
Thomas L (Hrsg) (2005) Labor und Diagnose. 6. Aufl. THBooks, Frankfurt/Main, S 1121f
Rose C, Dähnrich C, Probst C, Komorowski L, Stöcker W, Schlumberger W, Zillikens D (2008) Anti-GAF(3X)-ELISA (IgG) in combination with Anti-tTG-ELISA (IgA) identifies 100 % of celiac disease patients with dermatitis herpetiformis Duhring and positive intestinal biopsy (Marsh III). 6th International Congress on Autoimmunity in Porto, Portugal
Prause C, Ritter M, Probst C, Dähnrich C, Schlumberger W, Komorowski L, Lieske R, Richter T, Hauer AC, Stern M, Uhlig H, Laas M, Zimmer KP, Mothes T (2009) Antibodies against deamidated gliadin as new and accurate biomarkers of childhood coeliac disease. J Pediatr Gastroenterol Nutr 49:52-58
Warkentin TE, Heddle NM (2003) Laboratory diagnosis of immune heparin-induced thrombocytopenia. Curr Hematol Rep 2:148-157
Kivisakk P, Alm GV, Fredrikson S et al (2000) Neutralizing and binding anti-interferon-beta (IFN-beta) antibodies. A comparison between IFN-beta-1a and IFN-beta-1b treatment in multiple sclerosis. Eur J Neurol 7:27-34
Main J, McKenzie H, Yeaman GR et al (1988) Antibody to Saccharomyces cerevisiae (bakers’ yeast) in Crohn’s disease. BMJ 297:1105-1106
Teegen B, Müller-Kunert E, Zerbe B, Dähnrich C, Groeury M, Humbel RL, Schlumberger W, Stöcker W (2000) Prevalence of antibodies against Saccharomyces cerevisiae in the diagnosis of chronic-inflammatory bowel disease. J Lab Med 24:494
Damoiseaux JG, Bouten B, Linders AM, Austen J, Roozendaal C, Russel MG, Forget PP, Tervaert JW (2002) Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies for inflammatory bowel disease: High prevalence in patients with celiac disease J Clin Immunol 22(5):281-288
Lütticken R (1992) Streptococcae. In: Burkhardt F (Hrsg) Mikrobiologische Diagnostik. Georg Thieme Verlag, Stuttgart, S 51-62
Mueller-Eckhardt C, Kiefel V (Hrsg) (2004) Transfusionsmedizin:Grundlagen – Therapie – Methodik. 3. Aufl. Springer Berlin Heidelberg New York
Eckstein R (2005) Immunhämatologie und Transfusionsmedizin, 5. Aufl. Gustav Fischer, Stuttgart
Salama A, Mueller-Eckhardt C (1996) Nachweis von erythrozytären Antigenen und Antikörpern. In: Mueller-Eckhardt C (Hrsg) Transfusionsmedizin. 2. Aufl. Springer, Berlin Heidelberg New York, S 587-596
Mueller-Eckhardt C, Kiefel V (Hrsg) (2004) Transfusionsmedizin: Grundlagen – Therapie – Methodik. 3. Aufl. Springer Berlin Heidelberg New York
Eckstein R (2005) Immunhämatologie und Transfusionsmedizin, 5. Aufl. Gustav Fischer, Stuttgart
Salama A, Mueller-Eckhardt C (1996) Nachweis von erythrozytären Antigenen und Antikörpern. In: Mueller-Eckhardt C (Hrsg) Transfusionsmedizin. 2. Aufl. Springer, Berlin Heidelberg New York, S 587-596
Mueller-Eckhardt C, Kiefel V (Hrsg) (2004) Transfusionsmedizin: Grundlagen – Therapie – Methodik. 3. Aufl. Springer Berlin Heidelberg New York
Eckstein R (2005) Immunhämatologie und Transfusionsmedizin, 5. Aufl. Gustav Fischer, Stuttgart
American Association of Blood Banks (1999) Technical Manual 13th ed. S. Karger, Basel
Bencze K (1994) Antimony. In: Seiler HG, Sigel A, Sigel H (eds) (1994) Handbook on Metals in Clinical and Analytical Chemistry. Marcel Dekker, New York Basel Hong Kong, S 227-236
Durlinger AL, Visser JA, Themmen AP (2002 Regulation of ovarian function: the role of anti-Müllerian hormone. Reproduction 124(5):601-609 (Review).
Gnoth C, Schuring AN, Friol K, Tigges J, Mallmann P, Godehardt E 2008) Relevance of anti-Mullerian hormone measurement in a routine IVF program. Hum Reprod 23(6):1359-1365
Broekmans FJ, Visser JA, Laven JS, Broer SL, Themmen AP, Fauser BC (2008) Anti-Müllerian hormone and ovarian dysfunction. Trends Endocrinol Metab 19(9):340-347
Miller NJ, Rice-Evans C et al (1993) A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature infants. Clin Sci 84:407-412
Coughlin PB (2005) Antiplasmin. The forgotten serpin. FEBS Journal 272:4852-4857
Everson GT, Shiffman ML, Hoefs JC et al (2012) Quantitative liver function tests improve the prediction of clinical outcomes in chronic hepatitis C: Results from the hepatitis C antiviral long-term treatment against cirrhosis trial. Hepatology 55:1019-1029
Grieco A, Castellano R, Matera A (1998) Antipyrine clearance in chronic und neoplastic liver diseases: a study of 518 patients. J Gastroenterol Hepatol 13:460-466
Bachellerie JP, Michot B, Nicoloso M et al (1995) Antisense snoRNAs: A Family of Nucleolar RNAs with Long Complementarities to rRNA. Trends Biochem Sci 20:261-264
Bock SCC (2001) Antithrombin III and Heparin Cofactor II. In: Colman RW, Hirsh J, Marr VJ etde al (eds) Hemostasis and Thrombosis. Lippincott Williams & Wilkins, Philadelphia, pp 321-333
Kottke-Marchand K, Duncan A (2002) Antithrombin Deficiency. Arch Pathol Lab Med 126:1326-1336
Carrell RW, Lomas DA (2002) Alpha1-antitrypsin deficiency – a model for conformational diseases. N Engl J Med 346:45-53
Lammert F, Gressner A, Ritter K, Matern S (2005) Leber und Gallenblase/-wege. In: Guder WG, Nolte J (Hrsg) Das Laborbuch für Klinik und Praxis. Elsevier Urban & Fischer, München, Jena, S 158-159
Biedermann A, Köhnlein T (2006) Alpha-1-Antitrypsin-Mangel – eine versteckte Ursache der COPD. Dtsch Ärztelbl 103:A1828–A1832
Laposata M, Green D, Van Cott EM et al (1998) College of American Pathologists Conference XXXI on Laboratory Monitoring of Anticoagulant Therapy: the Clinical Use and Laboratory Monitoring of Low-Molecular-Weight Heparin, Danaparoid, Hirudin and Related Compounds, and Argatroban. Arch Pathol Lab Med 122:799-807
Koeppen KM, Heller S (1991) Differentialblutbild (panoptische Färbung). In: Boll I, Heller S (Hrsg) Praktische Blutzelldiagnostik, Springer-Verlag, Berlin Heidelberg New York, S 173
BIPM, IEC, IFCC, ILAC, ISO, IUPAC, IUPAP, OIML (2010). Internationales Wörterbuch der Metrologie (VIM) Deutsch-englische Fassung. ISO/IEC-Leitfaden 99:2007. 3. Aufl. Beuth-Verlag, Berlin
Yung-Chang Chen, Chen-Yin Chen, Hsiang-Hao Hsu, Chung-Wei Yang, Ji-Tseng Fang (2002) APACHE III Scoring System in Critically Ill Patients with Acute Renal Failure Requiring Dialysis. Dialysis Transplantation 31: 222-233
Hesse A, Claßen A, Röhle G (1989) Labordiagnostik bei Urolithiasis. WVG, Stuttgart
Asper A (1982) Harnsteinanalytik. Habilitationsschrift. Medizinische Fakultät Zürich
Falbe J, Regitz M (1996) Römpp Chemie Lexikon. Georg Thieme Verlag, Stuttgart New York
Schwandt P, Richter O, Parhofer KG (2007) Handbuch der Fettstoffwechselstörungen. 3. Aufl. Schattauer Verlag, Stuttgart
Schwandt P, Richter O, Parhofer KG (2007) Handbuch der Fettstoffwechselstörungen. 3. Aufl. Schattauer Verlag, Stuttgart
Hubacek JA (2005) Apolipoprotein A5 and triglyceridemia. Focus on the effects of the common variants. Clin Chem Lab Med 43:897-902
Schwandt P, Richter O, Parhofer KG (2007) Handbuch der Fettstoffwechselstörungen. 3. Aufl. Schattauer Verlag, Stuttgart
Mahley RW, Rall SC Jr (2000) Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet 1:507-537
Day JR, Albers JJ, Gilbert TL et al (1994) Purification and molecular cloning of human apolipoprotein F. Biochem Biophys Res Commun 203:1146-1151
Jones SE, Jomary C (2002) Clusterin. Int J Biochem Cell Biol 34:427-431
Ghosh P, Hale EA, Lakshman MR (2001) Plasma sialic-acid index of apolipoprotein J (SIJ): a new alcohol intake marker. Alcohol 25:173-179
Wolfrum C, Poy MN, Stoffel M (2005) Apolipoprotein M is required for prebeta-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis. Nat Med 11:418-422
Christoffersen C, Dahlbäck B, Nielsen LB (2006) Apolipoprotein M: progress in understanding its regulation and metabolic functions. Scand J Clin Lab Invest 66:631-638
Vaux DL, Strasser A (1996) The molecular biology of apoptosis. Proc Natl Acad Sci USA 93:2239-2244
Hilgers R-D, Bauer P, Scheiber V (2002) Einführung in die Medizinische Statistik. Springer-Verlag, Berlin Heidelberg New York
Zweig MH, Campbell G (1993) Receiver-operating characteristic (ROC) Plots: A fundamental evaluation tool in clinical medicine. Clin Chem 39:561-577
Tuerk C, Gold L (1990) Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249:505-510
Ellington AD, Szostak JW (1990) In vitro selection of RNA molecules that bind specific ligands. Nature 346:818-822
Bunka DH, Stockley PG (2006) Aptamers come of age – at last. Nat Rev Microbiol 4(8):588-596
Ng EW, Shima DT, Calias P, Cunningham ET Jr, Guyer DR, Adamis AP (2006) Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease. Nat Rev Drug Discov 5(2):123-132
Apt L, Downey WS (1955) Melena neonatorum: The swallowed blood syndrome; a simple test for the differentiation of adult and fetal hemoglobin in bloody stools. J Pediatr 47: 6-12
Thomas L (Hrsg) (2005) Labor und Diagnose. 6. Aufl. THBooks, Frankfurt/Main, S 1918f
Latscha HP, Linti GW, Klein HA (2004) Analytische Chemie. Chemie – Basiswissen III. Springer-Verlag, Berlin Heidelberg New York
Thomas L (1994) Arbeitsgemeinschaft Medizinische Laboratoriumsdiagnostik (AML) gegründet. Lab Med 18:342
DFG (2008) MAK- und BAT-Werte-Liste 2008. Wiley-VCH, Weinheim
Die Verordnung zum Schutz vor gefährlichen Stoffen (Gefahrstoffverordnung – GefStoffV) (2010) Bundesgesetzblatt I, S. 1643
Bundesministerium für Arbeit und Soziales. http://www.bmas.de/DE/Service/Gesetze/arbschg.html
http://www.nobel.se/medicine/laureates/1978/arber-autobio.html
Duran M (2008) Amino acids. In: Blau N, Duran M, Gibson KM (eds) Laboratory Guide to the Methods in Biochemical Genetics. Springer, Berlin Heidelberg New York, pp 53-90
Flynn NE, Meininger CJ, Haynes TE et al (2002) The metabolic basis of arginine nutrition and pharmacology. Biomed Pharmacother 56:427-438
Bremer HJ, Duran M, Kamerling JP et al (1981) Disturbances of Aminoacid Metabolism: Clinical Chemistry and Diagnosis, Urban & Schwarzenberg, Munich and Baltimore
Duran M (2008) Amino acids. In: Blau N, Duran M, Gibson KM (eds) Laboratory Guide to the Methods in Biochemical Genetics, Springer, Berlin Heidelberg New York, pp 53-90
Newton CR, Graham A, Heptinstall IE et al (1989) Analysis of Any Point Mutation in DNA. The Amplification Refractory Mutation System (ARMS). Nucleic Acids Res 17:2503-2515
Geisler J, Ekse D, Helle H et al (2008) An optimized, highly sensitive radioimmunoassay for the simultaneous measurement of estrone, estradiol and estrone sulfate in the ultra-low range in human plasma samples. J Steroid Biochem Mol Biol 109:90-95
Satoh K, Nonaka R, Ishikawa F et al (2008) In vitro screening assay for detecting aromatase activity using rat ovarian microsomes and estrone ELISA. Biol Pharm Bull 31:357-362.
Degel F (2009) Aromatics (BTEX). In: Külpmann WR (ed) Clincial toxicological analysis. Wiley-VCH, Weinheim, pp 523-531
Kommission „Human-Biomonitoring“ des Umweltbundesamtes (2003) Stoffmonographie Arsen – Referenzwert für Urin. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 46:1098-1106
BIPM, IEC, IFCC, ILAC, ISO, IUPAC, IUPAP, OIML (2010). Internationales Wörterbuch der Metrologie (VIM) Deutsch-englische Fassung. ISO/IEC-Leitfaden 99:2007. 3. Aufl. Beuth-Verlag, Berlin
Tryding N, Tufvesson C, Sonntag O (1996) Drug Effects in Clinical Chemistry. Clinically Important Analytical Interferences and Biological Effects of Drugs on Biochemical and Haematological Laboratory Investigations. 7th edn. AB Realtryk, Stockholm
Young DS (2000) Effects of Drugs on Clinical Laboratory Tests. 5th edn. AACC Press, Washington DC
Gladtke E, von Hattingberg HM (1973) Pharmakokinetik. Springer-Verlag, Berlin Heidelberg New York
Ashby W (1919. The determination of the length of life of transfused blood corpuscles in man. J Exp Med 29:267-281
Arndt T (2003) Asialotransferrin – An alternative to carbohydrate- deficient transferrin? Clin Chem 49:1022-1023
Wallace RB, Johnson MJ, Hirose T et al (1981) The Use of Synthetic Oligonucleotides as Hybridization Probes. II. Hybridization of Oligonucleotides of Mixed Sequence to Rabbit β-Globin DNA. Nucleic Acids Res 9:879-894
Bremer HJ, Duran M, Kamerling JP et al 1981) Disturbances of Aminoacid Metabolism: Clinical Chemistry and Diagnosis, Urban & Schwarzenberg, Munich and Baltimore
Duran M (2008) Amino acids. In: Blau N, Duran M, Gibson KM (eds) Laboratory Guide to the Methods in Biochemical Genetics. Springer, Berlin Heidelberg New York, pp53–90
Bremer HJ, Duran M, Kamerling JP et al 1981) Disturbances of Aminoacid Metabolism: Clinical Chemistry and Diagnosis, Urban & Schwarzenberg, Munich and Baltimore
Duran M (2008) Amino acids. In: Blau N, Duran M, Gibson KM (eds) Laboratory Guide to the Methods in Biochemical Genetics. Springer, Berlin Heidelberg New York, pp53–90
Schumann G et al (2002) IFCC Primary Reference Procedures for the Measurement of Catalytic Activity Concentrations of Enzymes at 37 °C, Part 5: Reference Procedure for the Measurement of Catalytic Concentration of Aspartate Aminotransferase. Clin Chem Lab Med 40:725–733
Ohmori T, Yatomi Y, Nonaka T et al (2006) Aspirin resistance detected with aggregometry cannot be explained by cyclooxygenase activity: involvement of other signaling pathway(s) in cardiovascular events of aspirin-treated patients. J Thromb Haemost 4: 1271–1278
Berzofsky JA, Epstein SL, Berkower IJ (1989) Antigenantibody interactions and monoclonal antibodies. In: Paul WA (ed) Fundamental Immunology. 2nd edn. Raven Press, New York
Siggaard-Andersen O, Engel K, Jorgensen K, Astrup P (1960) A Micro Method for the Determination of pH, Carbon Dioxide Tension, Base Excess and Standard Bicarbonate in Capillary Blood. Scand J Clin Lab Invest 12:172–176
Cannon RO (1998) Role of nitric oxide in cardiovascular disease: focus on the endothelium. Clin Chem 44:1809–1819
Schwedhelm E, Böger RH (2011) The role of asymmetric and symmetric dimethylarginines in renal disease. Nat Rev Nephrol 5: 275–285
Braden B, Lembcke B, Caspary WF (2003) Nichtinvasive Funktionsdiagnostik aus der Atemluft mit 13C-Atemtests. Dt Ärzteblatt 100:A3376–A3381
Henning BF, Doberauer C, Tepel M, Gillessen A (1997) H2-Atemtests. Internist Praxis 37:745–757
Schneider ARJ, Caspary WF, Stein J (2004) 13C-basierte Atemtests in der Leberfunktionsdiagnostik. Z Gastroenterol 42:269–275
Sperl W, Freisinger P (2004) Mitochondriale Enzephalomyopathien im Kindesalter – kritische Aspekte zu Diagnostik und Therapie. SPS Publications, Heilbronn
Welz B, Sperling M (1997) Atomabsorptionsspektrometrie. 4. Aufl. Wiley-VCH, Weinheim
Broekaert JAC (2002) Analytical Spectrometry with Flames and Plasmas. Wiley-VCH, Weinheim
Broekaert JAC (2002) Analytical Spectrometry with Flames and Plasmas. Wiley-VCH, Weinheim
Welz B, Sperling M (1997) Atomabsorptionspektrometrie. 4. Aufl. Wiley-VCH, Weinheim
Broekaert JAC (2002) Analytical Atomic Spectrometry with Flames and Plasmas. Wiley-VCH, Weinheim
Kellner R et al (eds) (2004) Analytical Chemistry. 2nd edn. Wiley-VCH, Weinheim
Altmann DG, Bland JM (1994) Statistical Notes: Diagnostic tests 3: receiver operating characteristic plots. BMJ 309:188
DIN EN ISO 9000:2005 „Qualitätsmanagementsysteme – Grundlagen und Begriffe“
Auer J (1906) Some hitherto undescribed structures found in the large lymphocytes of a case of acute leukaemia. Am J Med Sci 131:1002–1015
BIPM, IEC, IFCC, ILAC, ISO, IUPAC, IUPAP, OIML (2010). Internationales Wörterbuch der Metrologie (VIM) Deutsch-englische Fassung. ISO/IEC-Leitfaden 99:2007. 3. Aufl. Beuth-Verlag, Berlin
Ettre LS (1993) Nomenclature for Chromatography. Pure Appl Chem 65:819–872
Buschhausen-Denker G, Deitenbeck D (1995) Sicherheit in der Gentechnik. Handbuch für Projektleiter und Mitarbeiter in gentechnischen Anlagen. Ed. Temmen, Bremen
Falbe J, Regitz M (Hrsg) (1989) Römpp Chemie Lexikon. Georg Thieme Verlag, Stuttgart New York
BIPM, IEC, IFCC, ILAC, ISO, IUPAC, IUPAP, OIML (2010). Internationales Wörterbuch der Metrologie (VIM) Deutschenglische Fassung. ISO/IEC-Leitfaden 99:2007. 3. Aufl. Beuth-Verlag, Berlin
Weiß C (1999) Basiswissen Medizinische Statistik. Springer- Verlag, Berlin Heidelberg New York
ISO Statistics (1993) Vocabulary and symbols. Part 1. Probability and general statistical terms. ISO 3534-1, Geneva
Falbe J, Regitz M (Hrsg) (1989) Römpp Chemie Lexikon. Georg Thieme Verlag, Stuttgart New York
Ettre LS (1993) Nomenclature for Chromatography. Pure Appl Chem 65:819–872
Unger KK (Hrsg) (1989) Handbuch der HPLC. Teil 1 Leitfaden für Anfänger und Praktiker. GIT Verlag, Darmstadt
American Association of Blood Banks (1999) Technical Manual 13th edition, S. Karger, Basel
Salama A, Mueller-Eckhardt C (1996) Nachweis von erythrozytären Antigenen und Antikörpern. In: Mueller-Eckhardt C (Hrsg) Transfusionsmedizin. 2. Aufl. Springer, Heidelberg Berlin New York, 587–596
Giudice GJ, Emery DJ, Diaz LA (1992) Cloning and primary structural analysis of the bullous pemphigoid autoantigen BP180. J Invest Dermatol 99:243–250
Jainta S, Schmidt E, Bröcker EB, Zillikens D (2001) Diagnostik und Therapie bullöser Autoimmunerkrankungen der Haut. Deutsches Ärzteblatt 98:A1320–A1325
Sitaru C, Dähnrich C, Probst C, Komorowski L, Blöcker I, Schmidt E, Schlumberger W, Rose C, Stöcker W, Zillikens D (2007) Enzyme-linked immunosorbent assay using multimers of the 16th non-collagenous domain of the BP180 antigen for sensitive and specific detection of pemphigoid autoantibodies. Exp Dermatol 16:770–777
Dilling A, Rose C, Hashimoto T, Zillikens D, Shimanovich I (2007) Anti-p-200-Pemphigoid: a novel autoimmune subepidermal blistering disease. J Dermatol 34:1–8
Preisz K, Kárpáti S (2007) Paraneoplastic Pemphigus. Orv Hetil 148(21):979–983
Dainichi T, Kurono S, Ohyama B, Ishii N, Sanzen N, Hayashi M, Shimono C, Taniguchi Y, Koga H, Karashima T, Yasumoto S, Zillikens D, Sekiguchi K, Hashimoto T (2009) Anti-laminin gamma-1 pemphigoid. Proc Natl Acad Sci USA. 106(8):2800–2805
Probst C, Schlumberger W, Stöcker W, Recke A, Schmidt E, Hashimoto T, Zhu XJ, Zillikens D, Komorowski L (2009) Development of ELISA for the specific determination of autoantibodies against envoplakin and periplakin in paraneoplastic pemphigus. Clin Chim Acta 410(1–2):13–18
McConville J, Vincent A (2002) Diseases of the neuromuscular junction. Curr Opin Pharmacol 2:296–301
Lindstrom JM (2000) Acetylcholine receptors and myasthenia. Muscle Nerve 23:453–477
Wallukat K (2002) The β-adrenergic receptors. Herz 27:683–690
Jahns R, Boivin V, Hein L et al (2004) Direct evidence for a β1- adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy. J Clin Invest 113:1419–1429
Caforio AL, Daliento L, Angelini A et al (2005) Autoimmune myocarditis and dilated cardiomyopatha: focus on cardiac autoantibodies. Lupus 14:652–655
Nishikai M, Reichlin M (1980) Heterogeneity of precipitating antibodies in polymyositis and dermatomyositis. Characterization of the Jo-1 antibody system. Arthritis Rheum 23:881–888
Bernstein RM, Morgan SH, Chapman J, Bunn CC, Mathews MB, Turner- Warwick M, Hughes GR (1984) Anti-Jo-1 antibody: a marker for myositis with interstitial lung disease. Br Med J 289:151–152
Azad AK, Stanford DR, Sarkar S, Hopper AK (2001) Role of nuclear poos of aminoacyl-t-RNA synthetases in tRNA nuclear export. Mol Biol Cell 12(5):1381–1392
Saiz A, Dalmau J, Butler MH et al (1999) Anti-amphiphysin I antibodies in patients with paraneoplastic neurological disorders associated with small cell lung carcinoma. J Neurol Neurosurg Psychiatry 66:214–217
Rand JH, Wu XX, Lapinski R, van Heerde WL, Reutelingsperger CP, Chen PP, Ortel TL (2004) Detection of antibody-mediated reduction of annexin A5 anticoagulant activity in plasmas of patients with the antiphospholipid syndrome. Blood 104:2783–2790
Tomer A, Bar-Lev S, Fleisher S, Shenkman B, Friger M, Abu-Shakra M (2007) Antiphospholipid antibody syndrome: the flow cytometric annexin A5 competition assay as a diagnostic tool. Brit J Haematol 139:113–120
Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, Nakashima I, Weinshenker BG (2004) A serum autoantibody marker of neuromyelitis optica: Distinction from multiple sclerosis. Lancet 364:2106–2112.
Weinshenker BG, Wingerchuk DM (2008) Neuromyelitis optica: clinical syndrome and the NMO-IgG autoantibody marker. Curr Top Microbiol Immunol 318:343–356
Jarius S, Probst C, Borowski K, Franciotta D, Wildemann B, Stöcker W, Wandinger KP (2010) Standardized method for the detection of antibodies to aquaporin-4 based on a highly sensitive immunofluorescence assay employing recombinant target antigen. J Neurol Sci 291:52–56
McFarlane BM, McSorley CG, Vergani D et al (1986) Serum autoantibodies reacting with the hepatic asialoglycoprotein receptor protein (hepatic lectin) in acute and chronic liver disorders. J Hepatol 3:196–205
Schultz H, Weiss J, Carroll SF, Gross WL (2001) The endotoxin- binding bactericidal/permeability-increasing protein (BPI): a target antigen of autoantibodies. J leukoc Biol 69:505–512
Vincent A (1999) Antibodies to ion channels in paraneoplastic disorders. Brain Pathology 9:285–291
Lennon VA, Kryzer TJ, Griesmann GE et al (1995) Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes. N Engl J Med 332:1467–1474
Autoantikörper gegen Phospholipide
Casiano CA, Humbel RL, Peebles C et al (1995) Autoimmunity to the cell cycle-dependent centromere protein p330d/CENPF in disorders associated with cell proliferation. J Autoimmunity 8:575–586
Casiano CA, Landberg G, Ochs RL et al (1993) Autoantibodies to a novel cell cycle-regulated protein that accumulates in the nuclear matrix during S phase and is localized in the kinetochores and spindle midzone during mitosis. J Cell Sci 106:1045–1056
Vossenaar ER, Van Venrooij WJ (2004) Anti-CCP antibodies, a highly specific marker for (early) rheumatoid arthritis. Clin Appl Immunol Rev 4:239–262
Jelezarova E, Schlumberger M, Sadallah S et al (2001) A C3 convertase assay for nephritic factor functional activity. J Immunol Methods 251:45–52
Siegert CEH, Kazatchkine MD, Sjöholm A, Würzner R, Loos M, Daha MR (1999) Autoantibodies against C1q: view on clinical relevance and pathogenic roles. Clin Exp Immunol 116:4–8
Walport MJ (2002) Complement and systemic lupus erythematosus. Arthritis Res 4 (Suppl 3):S279–293
Mahoney MG, Wang Z, Rothenberger K, Koch PJ, Amagai M, Stanley JR (1999) Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris. J Clin Invest. 103:461–468
Dähnrich C, Rosemann A, Probst C, Komorowski L, Schlumberger W, Stöcker W, Recke A, Rose C, Zillikens D, Schmidt E (2009) ELISA using ectodomains of desmoglein 1 and 3 expressed in HEK293 for sensitive and specific detection of pemphigus autoantibodies. In: Conrad et al (eds): From pathogenesis to therapy of autoimmune diseases. Pabst Science Publishers Vol. 6:498–499
Isenberg D, Smeenk R (2002) Clinical laboratory assays for measuring anti-dsDNA antibodies. Where are we now? Lupus 11:797–800
Biesen R, Dähnrich C, Rosemann A, Hiepe F, Egerer K, Stöcker W, Schlumberger W (2008) Anti-dsDNA-NcX ELISA is superior to Farr-RIA and IFA using Crithidia luciliae for SLE diagnosis. Lupus 17:506–507
Colburn KK, Langga-Shariffi E, Kelly GT, Malto MC, Sandberg LB, Baydanoff S, Green LM (2003) Abnormalities of serum antielastin antibodies in connective tissue diseases. J Investig Med Mar 51:104–109
Zhi Liu (2003) Immunopathology of bullous pemphigoid, an autoimmune and inflammatory skin blistering disease. Keio J Med 52:128–133
Sitaru C, Dähnrich C, Probst C, Komorowski L, Blöcker I, Schmidt E, Schlumberger W, Rose C, Stöcker W, Zillikens D (2007) Enzymelinked immunosorbent assay using multimers of the 16th non-collagenous domain of the BP180 antigen for sensitive and specific detection of pemphigoid autoantibodies. Exp Dermatol 16:770–777
Mueller-Eckhard C (1996) Transfusionsmedizin. Springer- Verlag, Berlin Heidelberg New York
Tan EM, Chan EKL, Sullivan KF et al (1988) Antinuclear antibodies (ANAs): Diagnostically specific immune markers and clues toward the understanding of systemic autoimmunity. Clin Immunol Immunopathol 47:121–141
Czaja AJ (2007) Autoimmune liver diseases. Curr Opin Gastroenterol 23:255–262
Villalta D, Bizzaro N, Da Re M, Tozzoli R, Komorowski L, Tonutti E (2008) Diagnostic accuracy of four different immunological methods for the detection of anti-F-actin autoantibodies in type 1 autoimmune hepatitis and other liver-related disorders. Autoimmunity 41:105–110
Haneji N, Nakamura T, Takio K et al (1997) Identification of alpha-fodrin as a candidate autoantigen in primary Sjogren’s syndrome. Science 276:604–607
Ulbricht KU, Schmidt RE, Witte T (2003) Antibodies against alphafodrin in Sjogren’s syndrome. Autoimmun Rev 2:109–113
Lancaster E, Lai M, Peng X, Hughes E, Constantinescu R, Raizer J, Friedman D, Skeen MB, Grisold W, Kimura A, Ohta K, Iizuka T, Guzman M, Graus F, Moss SJ, Balice-Gordon R, Dalmau J (2010) Antibodies to the GABAB receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurol 9:67–76
Boronat A, Sabater L, Saiz A, Dalmau J, Graus F (2011) GABAB receptor antibodies in limbic encephalitis and GAD-associated neurologic disorders. Neurology 76:795–800
Wandinger KP, Klingbeil C, Gneiss C, Waters P, Dalmau J, Saschenbrecker S, Borowski K, Deisenhammer F, Vincent A, Probst C, Stöcker W (2011) Neue serologische Marker zur Differentialdiagnose der Autoimmun-Enzephalitis. J Lab Med 35:329–342
Jeffrey GP, Swanson NR, Yarred LJ et al (1990) Bile duct antibodies crossreacting with blood group antigens in primary sclerosing cholangitis. Gut 31:698–701
Vernino S (2007) Autoimmune and paraneoplastic channelopathies. Neurotherapeutics 4:305–314
Vernino S, Lindstrom J, Hopkins S, Wang Z, Low PA; Muscle Study Group (2008) Characterization of ganglionic acetylcholine receptor autoantibodies. J Neuroimmunol 197:63–69
Vernino S (2008) Neuronal acetylcholine receptor autoimmunity. Ann N Y Acad Sci 1132:124–128
Heidenreich F (1998) Autoantibodies associated with peripheral neuropathies. In: Conrad K, Humbel RL, Meurer M, Shoenfeld Y, Tan EM (eds) Pathogenic and diagnostic relevance of autoantibodies. Pabst Science Publishers 316–327
Meyer W, Schneider B, Klotz M, Schlumberger W, Stöcker W (2000) EUROLINE ganglioside profile: A new membrane test for the detection of autoantibodies against gangliosides. In: Conrad K et al (eds) Autoantigens and Autoantibodies: Diagnostic Tools and Clues to Understanding Autoimmunity. Pabst Science Publishers 619–620
Seah PP, Fry L, Rossiter MA et al (1971) Antireticulin antibodies in childhood coeliac disease. Lancet 2:681–682
Chorzelski TP, Sulej J, Tchorzewska H et al (1983) IgA class endomysium antibodies in dermatitis herpetiformis and coeliac disease. Ann NY Acad Sci 420:325–334
Dieterich W, Ehnis T, Bauer M et al (1997) Identification of tissue transglutaminase as the autoantigen of coeliac disease. Nat Med 3:797–801
Freitag T, Schulze-Koops H, Niedobitek G et al (2004) The role of the immune response against tissue transglutaminase in the pathogenesis of coeliac disease. Autoimmun Rev 3:13–20
Johnson GD, Holborow EJ, Glynn LE (1965) Antibody to smooth muscle in patients with liver disease. Lancet 2:878–879
Graus F, Delattre JY, Antoine JC, Dalmau J, Giometto B, Grisold W, Honnorat J, Smitt PS, Vedeler CH, Verschuuren JJ, Vincent A, Voltz R (2004) Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 75:1135–1140
Sabater L, Titulaer M, Saiz A, Verschuuren J, Güre AO, Graus F (2008) SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome. Neurology 70:924–928
Hellmark T, Johannson C, Wieslander J (1994) Characterization of anti-GBM antibodies involved in Goodpasture’s syndrome. Kidney Int 46:823–829
Bolton WK, Chen L, Hellmark T, Fox J, Wieslander J (2005) Molecular mapping of the Goodpasture’s epitope for glomerulonephritis. Trans Am Clin Climatol Assoc 116:229–236, discussion 237–238
Baekkeskov S, Aanstoot HJ, Christgau S, Reetz A, Solimena M, Cascalho M, Folli F, Richter-Olesen H, De Camilli P (1990) Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 347:151–156
Stöcker W, Schaper J, Schuhose C, Vieregge P, Kömpf D, Scriba PC (1990) Autoantibodies against cerebral gray matter in patients with insulin dependent diabetes mellitus. Immunobiol 181:223
Vieregge P, Branczyk B, Barnett W, Stöcker W, Soyka D, Kömpf D (1994) Stiff-Man-Syndrom. Bericht über vier Fälle. Nervenarzt 65:712–717
Pozzilli P, Manfrini S, Monetini L (2001) Biochemical markers of type 1 diabetes: clinical use. Scand J Clin Lab Invest 61 (Suppl 235) 38–44
Krüger C, Stöcker W, Schlosser M (2006) Glutamic Acid Decarboxylase Autoantibodies. In: Shoenfeld Y, Gershwin ME, Meroni PL (Hrsg) Autoantibodies. 2. Aufl. Elsevier, pp 369–378
Rogers SW, Andrews PI, Gahring LC et al (1994) Autoantibodies to glutamate receptor GluR3 in Rasmussen’s encephalitis. Science 265:648–651
Granata T (2003) Rasmussen’s syndrome. Neurol Sci Suppl 4:239–243
Lai M, Hughes EG, Peng X, Zhou L, Gleichmann AJ, Shu H, Matà S, Kremens D, Vitaliani R, Geschwind MD, Bataller L, Kalb RG, Davis R, Graus F, Lynch DR, Balice-Gordon R, Dalmau J (2009) AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol 65:424–434
Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M, Dessain SK, Rosenfeld MR, Balice-Gordon R, Lynch DR (2008) Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurology 7:1091–1098
Prüss H, Dalmau J, Harms L, Höltje M, Ahnert-Hilger G, Borowski K, Stoecker W, Wandinger KP (2010) Retrospective analysis of NMDA receptor antibodies in encephalitis of unknown origin. Neurology 75:1735–1739
Wandinger KP, Klingbeil C, Gneiss C, Waters P, Dalmau J, Saschenbrecker S, Borowski K, Deisenhammer F, Vincent A, Probst C, Stöcker W (2011) Neue serologische Marker zur Differentialdiagnose der Autoimmun-Enzephalitis. J Lab Med 35:329–342
Hutchinson M, Waters P, McHugh J, Gorman G, O’Riordan S, Connolly S, Hager H, Yu P, Becker C-M, Vincent A (2008) Progressive encephalomyelitis, rigidity, and myoclonus: A novel glycine receptor antibody. Neurology 71:1291–1292
Turner M, Irani S, Leite M, Nithi K, Vincent A, Ansorge O (2011) Progressive encephalomyelitis with rigidity and myoclonus: Glycine and NMDA receptor antibodies. Neurology 77:439
Piotrowicz A, Thümen A, Leite MI, Vincent A, Moser A (2011) A case of glycine-receptor-associated encephalomyelitis with rigidity and myoclonus (PERM): clinical course, treatment and CSF findings. J Neurol 258:2268–2270
Mas N, Saiz A, Leite MI, Waters P, Baron M, Castano D, Sabater L, Vincent A, Graus F (2011) Antiglycine-receptor encephalomyelitis with rigidity. J Neurol Neurosurg Psychiatry 82:1399–1401
Wandinger KP, Klingbeil C, Gneiss C, Waters P, Dalmau J, Saschenbrecker S, Borowski K, Deisenhammer F, Vincent A, Probst C, Stöcker W (2011) Neue serologische Marker zur Differentialdiagnose der Autoimmun-Enzephalitis. J Lab Med 35:329–342
Courvalin J-C, K Lassoued, E Bartnik, G Blobel, Wozniak RW (1990) The 210-kD nuclear envelope polypeptide recognized by human autoantibodies in primary biliary cirrhosis is the major glycoprotein of the nuclear pore. Clin Invest 86:279–285
Wesierska-Gadek J, Hohenauer H, Hitchman E, Penner E (1996) Antigp210 antibodies in sera of patients with primary biliary cirrhosis. Identification of a 64-kD fragment of gp210 as a major epitope. Hum Antibodies Hybridomas 7:167–174
Szostecki C, Guldner HH, Will H (1997) Autoantibodies against „nuclear dots“ in primary biliary cirrhosis. Semin Liver Dis 17:71–78
Invernizzi P, Selmi C, Ranftler C, Podda M, Wesierska-Gadek J (2005) Antinuclear antibodies in primary biliary cirrhosis. Semin Liver Dis 25:298–310
Levine JS, Branch DW, Rauch J (2002) The Antiphospholipid Syndrome. N Engl J Med 346:752–763
McNeil HP, Simpson RJ, Chesterman CN et al (1990) Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA 87:4120–4124
Wilson WA, Gharavi AE, Koike T (1999) International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Arthritis Rheum. 42:1309–1311
Stinton LM, Eystathioy T, Selak S et al (2004) Autoantibodies to protein transport and messenger RNA processing pathways: endosomes, lysosomes, Golgi complex, proteasomes, assemblyosomes, exosomes, and GW bodies. Clin Immunol 110:30–44
Van Der Woude FJ et al (1985) Autoantibodies against neutrophils and monocytes: tool for diagnosis and a marker of disease activity in Wegener’s granulomatosis. Lancet 1:425–429
Gross WL (1995) Antineutrophil cytoplasmic autoantibody testing in vasculitides. Rheum Dis Clin North Am 21:987–1011
Damoiseaux J, Buschtez M, Steller U, Zerbe B, Rosemann A, Fechner K, Schlumberger W, Cohen Tervaert JW, Stöcker W (2007) EUROPLUSTM ANCA BIOCHIP Mosaic: MPO and PR3 antigen dots improve the detection of ANCA by indirect immunofluorescence. In: Conrad K et al (eds) From Etiopathogenesis to the Prediction of Autoimmune Diseases: Relevance of Autoantibodies. Pabst Science Publishers, 5:485–486
Damoiseaux J, Dähnrich C, Rosemann A, Probst C, Komorowski L, Stegeman CA, Egerer K, Hiepe F, Paassen PV, Stöcker W, Schlumberger W, Tervaert JWC (2009) A novel ELISA using a mixture of human native and recombinant proteinase-3 significantly improves the diagnostic potential for ANCA-associated vasculitis. Ann Rheum Dis 68:228–233
Komorowski L, Teegen B, Probst C, Schlumberger W, Stöcker W (2009) ELISA for the detection of autoantibodies against DNA-bound lactoferrin in ulcerative colitis. In: Conrad K et al (eds) From Pathogenesis to the Therapy of Autoimmune Diseases. Pabst Science Publishers, pp 474–475
Jahns R, Boivin V, Hein L, Triebel S, Angermann CE, Ertl G, Lohse MJ (2004) Direct evidence for a beta 1-adrenergic receptor- directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy.J Clin Invest 113:1419–1429
Störk S, Boivin V, Horf R, Hein L, Lohse MJ, Angermann CE, Jahns R (2006) Stimulating autoantibodies directed against the cardiac beta-1- adrenergic receptor predict increased mortality in idiopathic cardiomyopathy. Am Heart J 152:697–704
Bernstein RM, Hobbs RN, Lea DJ et al (1985) Patterns of antihistone antibody specificity in systemic rheumatic disease. I Systemic lupus erythematosus, mixed connective tissue disease, primary sicca syndrome, and rheumatoid arthritis with vasculitis. Arthr Rheum 28:285–293
Xu Q, Kiechl S, Mayr M et al (1999) Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis: clinical significance determined in a follow-up study. Circulation 100:1169–1174
Voltz R (2002) Paraneoplastische neurologische Autoimmunerkrankungen. Nervenarzt 73: 909–929
Cunningham-Rundles C (1996) IgA Autoantibodies. In: Peter JB, Shoenfeld Y (eds) Autoantibodies. Elsevier, Amsterdam, pp 417–422
Strober W, Wochner RD, Barlow MH et al (1968) Immunoglobulin metabolism in ataxia telangiectasia. J Clin Invest 47:1905–1915
Hide M, Francis DM, Grattan CE et al (1994) The pathogenesis of chronic urticaria: new evidence suggest an auto-immune basis and implications for treatment. Clin Exp Allergy 24:624–627
Taylor SI, Barbetti F, Accili D, Roth J, Gorden P (1989) Syndromes of autoimmunity and hypoglycemia. Autoantibodies directed against insulin and its receptor. Endocrinol Metab Clin North Am Mar,18(1):123–143
Pozzilli P, Manfrini S, Monetini L (2001) Biochemical markers of type 1 diabetes: clinical use. Scand J Clin Lab Invest 235:38–44
Kiechle FL, Moore KH (2001) Insulin action and the clinical laboratory. J Clin Ligand Assay 24:217–228
Page KA, Dejardin S, Kahn CR, Kulkarni RN, Herold KC, Inzucchi SE (2007) A patient with type B insulin resistance syndrome, responsive to immune therapy. Nat Clin Pract Endocrinol Metab 3:835–840
Lan MS, Wasserfall C, MacLaren NK, Notkin AL (1996) IA-2, a transmembrane protein of the protein tyrosine phosphatase family, is a major autoantigen in insulin-dependent diabetes mellitus. Proc Natl Acad Sci 93:6367–6370
Pozzilli P, Manfrini S, Monetini L (2001) Biochemical markers of type 1 diabetes: clinical use. Scand J Clin Lab Invest 235:38–44
Broberger O, Perlman P (1959) Autoantibodies in human ulcerative colitis. J Exp Med 110:657–674
Stöcker W, Otte M, Ulrich S, Normann D, Stöcker K, Jantschek G (1984) Autoantikörper gegen exokrines Pankreas und gegen intestinale Becherzellen in der Diagnostik des Morbus Crohn und der Colitis ulcerosa. Dtsch Med Wschr 109:1963–1969
Stöcker W, Otte M, Scriba PC (1984) Zur Immunpathogenese des Morbus Crohn. Dtsch Med Wschr 109:1984–1986
Main J, McKenzie H, Yeaman GR, Kerr MA, Robson D, Pennington CR, Parrat D (1988) Antibody to Saccharomyces cerevisiae (bakers’ yeast) in Crohn’s disease. BMJ 297:1105–1106
Saxon A, Shanahan F, Landers C, Ganz T, Targan S (1990) A distinct subset of antineutrophil cytoplasmatic antibodies associated with inflammatory bowel disease. J Allergy Clin Immunol 86:202–210
Conrad K, Bachmann M, Stöcker W (2006) Anti-intestinal goblet cell antibodies. In: Shoenfeld Y, Gershwin ME, Meroni PL (eds) Autoantibodies. 2nd ed. Elsevier, Amsterdam, pp 417–422
Mardh S, Ma JY, Song YH et al (1991) Occurrence of autoantibodies against intrinsic factor, H-K-ATPase, and pepsinogen in atrophic gastritis and rheumatoid arthritis. Scand J Gastroenterol 26:1089–1096
Lai M, Huijbers MG, Lancaster E, Graus F, Bataller L, Balice- Gordon R, Cowell JK, Dalmau J (2010) Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol 9:776–785
Irani SR, Alexander S, Waters P, Kleopa KA, Pettingill P, Zuliani L, Peles E, Buckley C, Lang B, Vincent A (2010) Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotonia. Brain 133:2734–2748
Lancaster E, Huijbers MG, Bar V, Boronat A, Wong A, Martinez-Hernandez E, Wilson C, Jacobs D, Lai M, Walker RW, Graus F, Bataller L, Illa I, Markx S, Strauss KA, Peles E, Scherer SS, Dalmau J (2011) Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia. Ann Neurol 69:303–311
Wandinger KP, Klingbeil C, Gneiss C, Waters P, Dalmau J, Saschenbrecker S, Borowski K, Deisenhammer F, Vincent A, Probst C, Stöcker W (2011) Neue serologische Marker zur Differentialdiagnose der Autoimmun-Enzephalitis. J Lab Med 35:329–342
Mimori T, Akizuki M, Yamagata H et al (1981) Characterization of a high molecular weight acidic nuclear protein recognized by autoantibodies in sera from patients with polymyositis-scleroderma overlap. J Clin Invest 68:611–620
Mierau R, Genth E (1995) Diagnostische Bedeutung Sklerodermieund Myositis-assoziierter Autoantikörper. Z Rheumatol 54:39–49
Bertuch AA, Lundblad V (2003) The Ku heterodimer performs separable activities at double-strand breaks and chromosome termini. Mol Cell Biol 23:8202–8215
Komorowski L, Teegen B, Probst C, Schlumberger W, Stöcker W (2009) ELISA for the detection of autoantibodies against DNA-bound lactoferrin in ulcerative colitis. In: Conrad K et al (eds) From Pathogenesis to Therapy of Autoimmune Diseases. Pabst Science Publishers: 474–475
Courvalin JC, Worman HJ (1997) Nuclear envelope protein autoantibodies in primary biliary cirrhosis. Semin Liver Dis 17:79–90
Nesher G, Margalit R, Ashkenazi YJ (2001) Anti-nuclear envelope antibodies: Clinical associations. Semin Arthritis Rheum 30:313–320
Kain R, Exner M, Brandes R et al (2008) Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis. Nature Medicine 14 (10):1088–1096
Lapierre P, Hajoui O, Homberg JC et al (1999) Formiminotransferase cyclodeaminase is an organ-specific autoantigen recognized by sera of patients with autoimmune hepatitis. Gastroenterology 116:643–649
Homberg JC, Abuaf N, Bernard O, Islam S, Alvarez F, Khalil SH, Poupon R, Darnis F, Levy VG, Grippon P (1987) Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of „autoimmune“ hepatitis. Hepatology 7:1333–1339
Manns MP, Johnson EF, Griffin KJ, Tan EM, Sullivan KF (1989) Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1. J Clin Invest 83:1066– 1072
Rosenfeld MR, Eichen JG, Wade DF, Posner JB, Dalmau J (2001) Molecular and clinical diversity in paraneoplastic immunity to Ma proteins. Ann Neurol 50:339–348
Graus F, Delattre JY, Antoine JC, Dalmau J, Giometto B, Grisold W, Honnorat J, Smitt PS, Vedeler CH, Verschuuren JJ, Vincent A, Voltz R (2004) Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 75:1135–1140
Komatsu M, Goto M, Yamamoto A, Toyoshima I, Masamune O (1990) A new autoantibody, anti-210 kDa microtubule associated protein antibody, detected in the serum of patients with various liver diseases and SLE. Nihon Shokakibyo Gakkai Zasshi 87:2451–2456
Williams RC Jr., Sugiura K, Tan EM (2004) Antibodies to microtubule- associated protein 2 in patients with neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 50:1239–1247
Meurer M, Hausmann-Martinez-Pardo G, Braun-Falco O (1989) Spectrum of antinuclear and anti-cytoplasmic antibodies in dermatomyositis and polymyositis overlap syndromes. Hautarzt 40:623–629
Mierau R, Genth E (1995) Diagnostische Bedeutung Sklerodermieund Myositis-assozierter Autoantikörper. Z Rheumatol 54:39–49
Rozman B, Bozic B, Kos-Golja M et al (2000) Immunoserological aspects of idiopathic inflammatory muscle disease. Wien Klin Wochenschr 112:722–727
Berg PA, Klein R (1992) Antimitochondrial antibodies in primary biliary cirrhosis and other disorders: Definition and clinical relevance. Dig Dis 10:85–101
Jiang XH, Zhong RQ, Yu SQ, Hu Y, Li WW, Kong XT (2003) Construction and expression of a humanized M2 autoantigen trimer and its application in the diagnosis of primary biliary cirrhosis. World J Gastroenterol Jun 9:1352–1355
Dähnrich C, Pares A, Caballeria L, Rosemann A, Schlumberger W, Probst C, Mytilinaiou M, Bogdanos D, Vergani D, Stöcker W, Komorowski L (2009) New ELISA for detecting primary biliary cirrhosisspecific antimitochondrial antibodies. Clin Chem 55:978–985
Pluk H, van Engelen BG, Pruijn GJM (2011) Anti-Mup44: the first inclusion body myositis-specific autoantibody. In: Conrad K et al (eds) From prediction to prevention of autoimmune diseases: Autoantigens, Autoantibodies, Autoimmunity. Pabst Science Publishers, p 867
Vincent A, Bowen J, Newsom-Davis J et al (2003) Seronegative generalised myasthenia gravis: clinical features, antibodies, and their targets. Lancet Neurol 2:99–106
Hoch W, McConville J, Helms S et al (2001) Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat Med 7:365–368
Genain CP, Cannella B, Hauser SL, Raine CS (1999) Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nature Med 5:170–175
Jaskowski TD, Martins TB, Litwin CM et al (2004) Immunoglobulin (Ig)M antibody against myelin associated glycoprotein (MAG): A comparison of methods. J Clin Lab Anal 18:247–250
Lalive PH, Menge T, Delarasse C, Della Gaspera B, Pham- Dinh D, Villoslada P, von Bündingen HC, Genain CP (2006) Antibodies to native myelin oligodendrocyte glycoprotein are serologic markers of early inflammation in multiple sclerosis. PNAS 103:2280–2285
Brilot F, Dale RC, Selter RC, Grummel V, Kalluri SR, Aslam M, Busch V, Zhou D, Cepok S, Hemmer B (2009) Antibodies to native myelin oligodendrocyte glycoprotein in children with inflammatory demyelinating central nervous system disease. Ann Neurol 66:833–842
McLaughlin KA, Chitnis T, Newcombe J et al (2009) Age-dependent B cell autoimmunity to a myelin surface antigen in pediatric multiple sclerosis. J Immunol 183:4067–4076
Di Pauli F, Mader S, Rostasy K, Schanda K, Bajer-Kornek B, Ehling R, Deisenhammer F, Reindl M, Berger T (2011) Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseases. Clin Immunol 138:247–254
Pröbstel AK, Dornmair K, Bittner R, Sperl P, Jenne D, Magalhaes S, Villalobos A, Breithaupt C, Weissert R, Jacob U et al (2011) Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis. Neurology 77:580–588
Kitley J, Woodhall M, Waters P, Leite MI, Devenney E, Craig J, Vincent A, Palace J (2011) Myelin-oligodendrocyte glycoprotein antibodymediated acute inflammatory demyelinating disease mimicking neuromyelitis optica. Abstract: 5th Joint triennial congress of the European and Americas Committees for treatment and research in multiple sclerosis, Amsterdam, The Netherlands.
Gross WL (1995) Antineutrophil cytoplasmic autoantibody testing in vasculitides. Rheum Dis Clin North Am 21:987–1011
Anderson JR, Goudie RB, Gray KG, Timbury GC (1957) Autoantibodies in Addison’s disease. Lancet 272:1123–1124
Betterle C, Dal Pra C, Mantero F, Zanchetta R (2002) Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: Autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocr Rev 23: 327–364
Eisenbarth GS, Gottlieb PA (2004) Autoimmune polyendocrine syndromes. N Engl J Med 350:2068–2079
Chan KH, Vernino S, Lennon VA (2001) ANNA-3 antineuronal antibody: marker of lung cancer-related autoimmunity. Ann Neurol 50:301–311
Steblay RW, Rudofsky U (1971) Renal tubular disease and autoantibodies against tubular basement membrane induced in guinea pigs. J Immunol 107:589–594
Schlumberger W, Olbrich S, Müller-Kunert E et al (1994) Autoantikörper-Diagnostik mit der Substratkombination Humane Epithelzellen (HEp-2) und Primatenleber. Differenzierung der Antikörper durch Enzymimmuntests. Eigenverlag der EUROIMMUN AG, Lübeck, S 1–28
Suer W, Dähnrich C, Schlumberger W, Stöcker W (2004) Autoantibodies in SLE but not in scleroderma react with proteinstripped nucleosomes. J Autoimmun 22:325–334
Stinton LM, Barr SG, Tibbles LA, Yilmaz S, Sar A, Benedikttson H, Fritzler MJ (2007) Autoantibodies in lupus nephritis patients requiring renal transplantation. Lupus 16:394–400
Wandinger KP, Klingbeil C, Gneiss C, Waters P, Dalmau J, Saschenbrecker S, Borowski K, Deisenhammer F, Vincent A, Probst C, Stöcker W (2011) Neue serologische Marker zur Differentialdiagnose der Autoimmun-Enzephalitis. J Lab Med 35:329–342
Blaes F, Grisold W, Grabbe S, Hübner J, Kleeberg U, Krege S, Leypoldt F, Rauer S, Roelcke U, Schreckenberger M, Singer S, Stummer W, Voltz, R, Wandinger KP, Weller M, Wörmann B (2012) Paraneoplastische Syndrome. Leitlinien für Diagnostik und Therapie der Deutschen Gesellschaft für Neurologie. 5., überarb. Aufl. Thieme Verlag (im Druck)
Salonen JT, Yla-Herttuala S, Yamamoto R et al (1992) Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet 339:883–887
Soussi T (2000) p53 Antibodies in the sera of patients with various types of cancer: a review. Cancer Res 60:1777–1788
Crawford LV, Pim DC, Bulbrook RD (1982) Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer. Int J Cancer 30:403–408
Bottazzo GF, Florin-Christensen A, Doniach D (1974) Isletcell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 2:1279–1283
Stöcker W, Otte M, Ulrich S, Normann D, Stöcker K, Jantschek G (1984) Autoantikörper gegen exokrines Pankreas und gegen intestinale Becherzellen in der Diagnostik des Morbus Crohn und der Colitis ulcerosa. Dtsch Med Wochenschr 109:1963–1969
Stöcker W, Otte M, Ulrich S, Normann D, Finkbeiner H, Stöcker K, Jantschek G, Scriba PC (1987) Autoimmunity to pancreatic juice in Crohn’s disease. Results of an autoantibody screening in patients with chronic inflammatory bowel disease. Scand J Gastroenterol Suppl 139:41–52
Roggenbuck D, Hausdorf G, Martinez-Gamboa L, Reinhold D, Büttner T, Büning C, Feist E, Conrad K (2009) The zymogen granule membrane glycoprotein GP2 is a major autoantigen of pancreatic antibodies –relevance in diagnostics and pathogenesis of Crohn’s disease. In: Conrad K et al (eds) From pathogenesis to therapy of autoimmune diseases. Pabst Science Publishers, pp 449–462
Roggenbuck D, Hausdorf G, Martinez-Gamboa L, Feist E, Büttner T, Reinhold D, Jungblut PR, Porstmann T, Laass MW, Büning C, Henker J, Conrad K (2009) Identification of GP2, the major zymogen granule membrane glycoprotein, as the autoantigen of pancreatic antibodies in Crohn’s disease. Gut 58:1620–1628
Stöcker W, Teegen B, Probst C, Aulinger-Stöcker K, Ludwig D, Glocker MO, and Komorowski L (2009) CUZD1 and GP2 are the exocrine pancreas autoantigens in Crohn’s disease. In: Conrad K et al (eds) From pathogenesis to therapy of autoimmune diseases. Pabst Science Publishers:463–473
Taylor KB, Roitt IM, Doniach D et al (1962) Autoimmune phenomena in pernicious anaemia: Gastric antibodies. Br Med J 2:1347–13527
Vernino S, Lennon V (2000) New Purkinje cell antibody (PCA-2): marker of lung cancer-related neurological autoimmunity. Ann Neurol 47:297–305
Graus F, Delattre JY, Antoine JC, Dalmau J, Giometto B, Grisold W, Honnorat J, Smitt PS, Vedeler CH, Verschuuren JJ, Vincent A, Voltz R (2004) Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 75:1135–1140
Miyachi K, Fritzler MJ, Tan CK (1978) Autoantibody to a nuclear antigen in proliferating cells. J Immunol 121:2228–2234
Kawamura K, Kobayashi Y, Tanaka T et al (2000) Intranuclear localization of proliferating cell nuclear antigen during the cell cycle in renal cell carcinoma. Anal Quant Cytol Histol 22:107–113
Beck LH, Bonegio RGB, Lambeau G, Beck DM, Powell DW, Cummins TD, Klein JB, Salant DJ (2009) M-type Phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 361:11–21
Hoxha E, Harendza S, Zahner G, Panzer U, Steinmetz O, Fechner K, Helmchen U, Stahl RA (2011) An immunofluorescence test for phospholipase-A2-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis. Nephrol Dial Transplant 26:2526–2532
Gunnarsson I, Schlumberger W, Rönnelid J (2011) PLA2 receptor antibodies as serological markers of idiopathic membranous nephritis are absent in active membranous lupus nephritis. In: Conrad K et al (Hrsg) From prediction to prevention of autoimmune diseases: Autoantigens, Autoantibodies, Autoimmunity. Pabst Science Publishers, pp 232–233
Wilson WA, Gharavi AE, Koike T et al (1999) International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 42:1309–1311
Cervera R, Piette JC, Font J et al (2002) Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 46:1019–1027
Alarcon-Segovia D, Cabral AR (2000) The anti-phospholipid antibody syndrome: clinical and serological aspects. Baillieres Best Pract Res Clin Rheumatol 14:139–150
Levine JS, Branch DW, Rauch J (2002) The antiphospholipid syndrome. N Engl J Med 346:752–763
Sternsdorf T, Guldner HH, Szostecki C, Grotzinger T, Will H (1995) Two nuclear dot-associated proteins, PML and Sp100, are often co-autoimmunogenic in patients with primary biliary cirrhosis. Scand.J Immunol 42:257–268
Szostecki C, Guldner HH, Will H (1997) Autoantibodies against „nuclear dots“ in primary biliary cirrhosis. Semin Liver Dis 17:71–78
Invernizzi P, Selmi C, Ranftler C, Podda M, Wesierska-Gadek J (2005) Antinuclear antibodies in primary biliary cirrhosis. Semin Liver Dis 25:298–310
Reichlin M, Maddison PJ, Targoff I, Bunch T, Arnett F, Sharp G, Treadwell E, Tan EM (1984) Antibodies to a nuclear/nucleolar antigen in patients with polymyositis overlap syndromes. J Clin Immunol 4:40–44
Meyer W, Scheper T, Janssen A, Torkler S, Schlumberger W, Stöcker W (2007) EUROLINE Myositis Profile: A newly developed line immunoassay for the detection of myositis specific antibodies. In: Conrad K et al (eds) From Etiopathogenesis to the Prediction of Autoimmune Diseases: Relevance of Autoantibodies. Pabst Science Publishers 5:612–613
Hanke K, Brückner C, Dähnrich C, Huscher D, Becker M, Komorowski L, Meyer W, Jansen A, Backhaus M, Becker M, Kill A, Egerer K, Burmester G, Hiepe F, Schlumberger W, Riemekasten G (2009) Antibodies against PM/Scl-75 and PM/Scl-100 are independent markers for different subsets of systemic sclerosis patients. Arthritis Res Ther 11:R22
Van Der Woude FJ, Rasmussen N, Lobatto S, Wiik A, Permin H, Van Es LA, Van Der Giessen M, Van Der Hem GK, The TH (1985) Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener’s granulomatosis. Lancet 1:425–429
Savage COS, Winearls CG, Jones S et al (1987) Prospective study of radioimmunoassay for antibodies against neutrophil cytoplasm in diagnosis of systemic vasculitis. Lancet 1:1389–1393
Sun J, Fass DN, Viss MA, Hummel AM, Tang H, Homburger HA, Specks U (1998) A proportion of proteinase 3 (PR3)-specific antineutrophil cytoplasmic antibodies (ANCA) only react with PR3 after cleavage of its N-terminal activation dipeptide. Clin Exp Immunol 114:320–326
Savige J, Gillis D, Benson E et al (1999) International consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA). Am J Clin Pathol 111:507–513
Damoiseaux J, Buschtez M, Steller U, Zerbe B, Rosemann A, Fechner K, Schlumberger W, Cohen Tervaert JW, Stöcker W (2007) EUROPLUS ™ ANCA BIOCHIP Mosaic: MPO and PR3 antigen dots improve the detection of ANCA by indirect immunofluorescence. In: Conrad K et al (eds) From Etiopathogenesis to the Prediction of Autoimmune Diseases: Relevance of Autoantibodies. Pabst Science Publishers 5:485–486
Damoiseaux J, Steller U, Buschtez M, Vaessen M, Rosemann A, van Paassen P, Stöcker W, Fechner K, Cohen Tervaert JW (2009) EUROPLUS ANCA BIOCHIP mosaic: PR3 and MPO antigen microdots improve the laboratory diagnostics of ANCA-associated vasculitis. J Immunol Methods 348:67–73
Damoiseaux J, Dähnrich C, Rosemann A, Probst C, Komorowski L, Stegeman CA, Egerer K, Hiepe F, van Paassen P, Stöcker W, Schlumberger W, Cohen Tervaert JW (2009) A novel ELISA using a mixture of human native and recombinant proteinase-3 significantly improves the diagnostic potential for ANCA-associated vasculitis. Ann Rheum Dis 68:228–233
Strauss AJ, Seegal BC, Hsu KC et al (1960) Immunofluorescence demonstration of a muscle binding, complement-fixing serum globulin fraction in myasthenia gravis. Proc Soc Exp Biol Med 105:184–191
Steiner G, Smolen J (2002) Autoantibodies in rheumatoid arthritis and their clinical significance. Arthritis Res 4(Suppl 2):1–5
Elkon KB, Bonfa E, Weissbach H, Brot N (1994) Antiribosomal antibodies in SLE, infection, and following deliberate immunization. Adv Exp Med Biol 347:81–92
Caponi L, Giordano A, Bartoloni EB, Gerli R (2003) Detection of antiribosome antibodies: a long story of lights and shadows. Clin Exp Rheumatol 21:771–778
Gressner AM, Wool IG (1974) The phosphorylation of liver ribosomal proteins in vivo. J Biol Chem 249:6917–6925
Després N, Boire G, Lopez-Longo FJ, Ménard HA (1994) The Sa system: a novel antigen-antibody system specific for rheumatoid arthritis. J Rheumatol 21:1027–1033
Vossenaar ER, Després N, Lapointe E, Van Der Heijden A, Lora M, Senshu T, van Venrooij WJ, Ménard HA (2004) Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin. Arthritis Res Ther 6:R142–150
Ménard HA (2007) Anti-CCP versus anti-Sa antibodies for the diagnosis of RA. Nat Clin Pract Rheumatol 3:76–77
Tan EM, Chan EKL, Sullivan KF, Rubin RL (1988) Antinuclear antibodies (ANAs): Diagnostically specific immune markers and clues toward the understanding of systemic autoimmunity. Clin Immunol Immunopathol 47:121–141
Fritzler MJ (1993) Autoantibodies in Scleroderma. The Journal of Dermatology 20:257–268
Hanke K, Dähnrich C, Brückner C, Huscher D, Becker M, Jansen A, Meyer W, Egerer K, Hiepe F, Burmester G, Schlumberger W, Riemekasten G (2009) Diagnostic value of anti-topoisomerase I antibodies in a large monocentric cohort. Arthritis Res Ther 11:R28
Baeres M, Herkel J, Czaja AJ et al (2002) Establishment of standardized SLA/LP immunoassays: specificity for autoimmune hepatitis, worldwide occurrence, and clinical characteristics. Gut 51:259–264
Baeres M, Herkel J, Czaja AJ et al (2002) Establishment of standardized SLA/LP immunoassays: specificity for autoimmune hepatitis, worldwide occurrence, and clinical characteristics. Gut 51:259–264
Wies I, Brunner S, Henninger J et al (2000) Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis. Lancet 355:1510–1515
Tan EM, Chan EKL, Sullivan KF et al (1988) Antinuclear antibodies (ANAs): Diagnostically specific immune markers and clues toward the understanding of systemic autoimmunity. Clin Immunol Immunopathol 47:121–141
MacSween RN, Goudie RB, Anderson JR et al (1967) Occurrence of antibody to salivary duct epithelium in Sjogren’s disease, rheumatoid arthritis, and other arthritides. A clinical and laboratory study. Ann Rheum Dis 26:402–411
Andrade LE, Chan EK, Peebles CL, Tan EM (1996) Two major autoantigen-antibody systems of the mitotic spindle apparatus. Arthritis Rheum 39:1643–1653
Whitehead CM, Winkfein RJ, Fritzler MJ, Rattner JB (1996) The spindle kinesin-like protein HsEg5 is an autoantigen in systemic lupus erythematosus. Arthritis Rheum 39:1635–1642
Grypiotis P, Ruffatti A, Tonello M, Winzler C, Radu C, Zampieri S, Favaro M, Calligaro A, Todesco S (2002) Clinical significance of fluoroscopic patterns specific for the mitotic spindle in patients with rheumatic diseases. Reumatismo 54:232–237
Bonaci-Nikolic B, Andrejevic S, Bukilica M, Urosevic I, Nikolic M (2006) Autoantibodies to mitotic apparatus: Association with other autoantibodies and their clinical significance. J Clin Immunol 26:438–446
Mozo L, Gutiérrez C, Gómez J (2008) Antibodies to mitotic spindle apparatus: Clinical significance of NuMA and HsEg5 autoantibodies. J Clin Immunol 28:285–290
Tan EM, Chan EKL, Sullivan KF, Rubin RL (1988) Antinuclear antibodies (ANAs): Diagnostically specific immune markers and clues toward the understanding of systemic autoimmunity. Clin Immunol Immunopathol 47:121–141
Boire G, Gendron M, Monast N, Bastin B, Ménard HA (1995) Purification of antigenically intact Ro ribonucleoproteins; biochemical and immunological evidence that the 52-kDa protein is not a Ro protein. Clin exp Immunol 100:489–498
Meyer W, Scheper T, Siegemund M, Takeuchi K, Schlumberger W, Stöcker W (2004) The SS-A/Ro60 kDa protein is sufficient for the detection of autoantibodies against SS-A. In: Conrad K et al (eds) From animal models to human genetics: Research on the induction and pathogenicity of autoantibodies. Pabst Science Publishers 4:525–526
Gordon P, Khamashta MA, Rosenthal E, Simpson JM, Sharland G, Brucato A, Franceschini F, De Bosschere K, Meheus L, Meroni PL, Hughes GR, Buyon J (2004) Anti-52 kDa Ro, anti-60 kDa Ro, and anti- La antibody profiles in neonatal lupus. J Rheumatol 31:2480–2487
Anderson JR, Goudie RB, Gray K et al (1968) Immunological features of idiopathic Addison’s disease: an antibody to cells producing steroid hormones. Clin Exp Immunol 3:107–117
Betterle C, Dal Pra C, Mantero F et al (2002) Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: Autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocrine Reviews 23:327–364
Seissler J, Schott M, Steinbrenner H et al (1999) Autoantibodies to adrenal cytochrome P450 antigens in isolated Addison’s disease and autoimmune polyendocrine syndrome type II. Exp Clin Endocrinol Diabetes 107:208–213
Mueller-Eckhard C (1996) Transfusionsmedizin. Springer- Verlag, Berlin Heidelberg New York
Gentile F, Conte M, Formisano S (2004) Thyroglobulin as an autoantigen: What we can learn about immunopathogenicity from the correlation of antigenic properties with protein structure? Immunology 112:13–25
Aarli JA, Stefansson K, Marton LS et al (1990) Patients with myasthenia gravis and thymoma have in their sera IgG autoantibodies against titin. Clin Exp Immunol 82:284–288
Romi F, Skeie GO, Aarli JA et al (2000) Muscle autoantibodies in subgroups of myasthenia gravis patients. J Neurol 247:369–375
Bernal F, Shams’ili S, Rojas I, Sanchez-Valle R, Saiz A, Dalmau J, Honnorat J, Sillevis Smitt P, Graus F (2003) Anti-Tr antibodies as markers of paraneoplastic cerebellar degeneration and Hodgkin’s disease. Neurology 60:230–234
Graus F, Delattre JY, Antoine JC, Dalmau J, Giometto B, Grisold W, Honnorat J, Smitt PS, Vedeler CH, Verschuuren JJ, Vincent A, Voltz R (2004) Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 75:1135–1140
Orgiazzi J (2000) Anti-TSH receptor antibodies in clinical practice. Endocrinol Metab Clin North Am 29:339–355
Rees Smith B (2001) Thyroid autoantibodies. Scand J Clin Lab Invest Suppl 61:45–52
Saravanan P, Dayan CM (2001) Thyroid autoantibodies. Endocrinol Metab Clin North Am 30:315–337
Tan EM, Chan EKL, Sullivan KF et al (1988) Antinuclear antibodies (ANAs): Diagnostically specific immune markers and clues toward the understanding of systemic autoimmunity. Clin Immunol Immunopathol 47:121–141
Scherbaum WA, Bottazzo GF (1983) Autoantibodies to vasopressin cells in idiopathic diabetes insipidus: evidence for an autoimmune variant. Lancet 1:897–901
Pivonello R, De Bellis A, Faggiano A et al (2003) Central diabetes insipidus and autoimmunity: relationship between the occurrence of antibodies to arginine vasopressin-secreting cells and clinical, immunological, and radiological features in a large cohort of patients with central diabetes insipidus of known and unknown etiology. J Clin Endocrinol Metab 88:1629–1636
Voltz R (2002) Paraneoplastische neurologische Autoimmunerkrankungen. Nervenarzt 73:909–929
Tan EM, Chan EKL, Sullivan KF, Rubin RL (1988) Antinuclear antibodies (ANAs): Diagnostically specific immune markers and clues toward the understanding of systemic autoimmunity. Clin Immunol Immunopathol 47:121–141
Fritzler MJ (1993) Autoantibodies in scleroderma. J Dermatol 20:257– 68
Schlumberger W, Olbrich S, Müller-Kunert E, Stöcker W (1994) Autoantikörper-Diagnostik mit der Substratkombination: Humane Epithelzellen (HEp-2) und Primatenleber. Differenzierung der Antikörper durch Enzymimmuntests. Eigenverlag der EUROIMMUN AG, Lübeck, Deutschland
Genth E, Mierau R (1995) Diagnostische Bedeutung Sklerodermieund Myositis-assoziierter Autoantikörper. Z Rheumatol 54:39–49
Schlumberger W, Meyer W, Proost S, Dähnrich C, Müller-Kunert E, Sonnenberg K, Olbrich S, Stöcker W (1995) The new EUROBLOT technology: Differentiation of Autoantibodies against cell nuclei. Eur J Clin Chem Clin Biochem 33:A68–A69
Suer W, Dähnrich C, Schlumberger W, Stöcker W (2004) Autoantibodies in SLE but not in scleroderma react with protein-stripped nucleosomes. J Autoimmun 22:325–334
Yamasaki Y, Narain S, Yoshida H, Hernandez L, Barker T, Hahn PC, Sobel ES, Segal MS, Richards HB, Chan EK, Reeves WH, Satoh M (2007) Autoantibodies to RNA helicase A: A new serologic marker of early lupus. Arthritis Rheum 56:596–604
Gavanescu I, Vazquez-Abad D, McCauley J, Senecal JL, Doxsey S (1999) Centrosome proteins: a major class of autoantigens in scleroderma. J Clin Immunol 19:166–171
Moroi Y, Peebles C, Fritzler MJ, Steigerwald J, Tan EM (1980) Autoantibody to centromere (kinetochore) in scleroderma sera. Proc Natl Acad Sci 77:1627–1631
Meurer M, Scharf A, Luderschmidt C, Braun-Falco O (1985) Zentromerantikörper und Antikörper gegen Scl-70-Nucleoprotein bei progressiver systemischer Sklerodermie: Diagnostische und prognostische Bedeutung. Dtsch Med Wschr 110:8–14
Hanke K, Uibel S, Brückner C, Dähnrich C, Egerer K, Hiepe F, Schlumberger W, Riemekasten G (2007) Antibodies to CENP-B antigen identify a subgroup of systemic sclerosis patients presenting more frequently sicca syndrome and less frequently lung fibrosis, cardiac and vascular involvement – analysis of the Charité SSc cohort.
In: Conrad K et al (eds) From Etiopathogenesis to the Prediction of Autoimmune Diseases: Relevance of Autoantibodies. Pabst Science Publishers 5:477–478
Wenzlau JM, Juhl K, Yu L, Moua O, Sarkar SA, Gottlieb P, Rewers M, Eisenbarth GS, Jensen J, Davidson HW, Hutton C (2007) The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci USA 104:17040–17045
Wenzlau JM, Hutton JC, Davidson HW (2008) New antigenic targets in type 1 diabetes. Curr Opin Endocrinol Diabetes Obes 15:315–320
Wenzlau JM, Liu Y, Yu L, Moua O, Fowler KT, Rangasamy S, Walters J, Eisenbarth GS, Davidson HW, Hutton JC (2008) A common nonsynonymous single nucleotide polymorphism in the SLC30A8 gene determines ZnT8 autoantibody specificity in type 1 diabetes. Diabetes 57:2693–2697
Leung PS, Iwayama T, Prindiville T et al (1992) Use of designer recombinant mitochondrial antigens in the diagnosis of primary biliary cirrhosis. Hepatology 15:367–372
Szostecki C, Will H, Netter HJ et al (1992) Autoantibodies to the nuclear Sp100 protein in primary biliary cirrhosis and associated diseases: epitope specificity and immunoglobulin class distribution. Scand J Immunol 36:555–564
Sternsdorf T, Guldner HH, Szostecki C et al (1995) Two nuclear dotassociated proteins, PML and Sp100, are often co-autoimmunogenic in patients with primary biliary cirrhosis. Scand J Immunol 42:257– 268
Wesierska-Gadek J, Hohenauer H, Hitchman E et al (1996) Antigp210 antibodies in sera of patients with primary biliary cirrhosis. Identification of a 64 kD fragment of gp210 as a major epitope. Hum Antibodies Hybridomas 7:167–174
Wesierska-Gadek J, Hohenauer H, Hitchman E et al (1996) Autoantibodies against nucleoporin p62 constitute a novel marker of primary biliary cirrhosis. Gastroenterology 110:840–847
Szostecki C, Guldner HH, Will H (1997) Autoantibodies against „nuclear dots“ in primary biliary cirrhosis. Semin Liver Dis 17:71–78
Zuchner D, Sternsdorf T, Szostecki C et al (1997) Prevalence, kinetics, and therapeutic modulation of autoantibodies against Sp100 and promyelocytic leukemia protein in a large cohort of patients with primary biliary cirrhosis. Hepatology 26:1123–1130
Lapierre P, Hajoui O, Homberg JC et al (1999) Formiminotransferase cyclodeaminase is an organ-specific autoantigen recognized by sera of patients with autoimmune hepatitis. Gastroenterology 116:643–649
Wies I, Brunner S, Henninger J et al (2000) Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis. Lancet 355:1510–1515
Invernizzi PM, Podda PM, Battezzati A et al (2001) Autoantibodies against nuclear pore complexes are associated with more active and severe liver disease in primary biliary cirrhosis. J Hepatol 34:366–372
Invernizzi P, Selmi C, Ranftler C et al (2005). Antinuclear antibodies in primary biliary cirrhosis. Semin Liver Dis 25:298–310
Salama A, Gaedicke G (2006) Autoimmunhämolytische Anämien. In: Gadner H, Gaedicke G, Niemeyer C, Ritter J (Hrsg) Pädiatrische Hämatologie: Anämien und Hämoglobinopathen, Springer- Verlag, Berlin Heidelberg New York, 147–154
Eckstein R (2005) Immunhämatologie und Transfusionsmedizin. 5. Aufl. Gustav Fischer, Stuttgart
Murphy K, Travers P, Walport M (2011) Janeway’s Immunobiology, 8th ed. Taylor & Francis Ltd
Nakamura RM (2001) Concepts of Autoimmunity and Autoimmune Diseases. In: Nakamura RM, Keren DF, Bylund DJ (eds) Clinical and Laboratory Evaluation of Human Autoimmune Diseases, ASCP Press, Chicago, pp 13–35
Nakamura RM (2001) Concepts of Autoimmunity and Autoimmune Diseases. In: Nakamura RM, Keren DF, Bylund DJ (eds) Clinical and Laboratory Evaluation of Human Autoimmune Diseases, ASCP Press, Chicago, pp 13–35
Nakamura RM (2001) Concepts of Autoimmunity and Autoimmune Diseases. In: Nakamura RM, Keren DF, Bylund DJ (eds) Clinical and Laboratory Evaluation of Human Autoimmune Diseases, ASCP Press, Chicago, pp 13–35
Murphy K, Travers P, Walport M (2011) Janeway’s Immunobiology, 8th ed. Taylor & Francis
Nagamine K, Peterson P, Scott HS et al (1997) Positional cloning of the APECED gene. Nat Genet 17:393–398
Nakamura RM (2001) Concepts of Autoimmunity and Autoimmune Diseases. In: Nakamura RM, Keren DF, Bylund DJ (eds) Clinical and Laboratory Evaluation of Human Autoimmune Diseases, ASCP Press, Chicago, pp 13–35
Mueller-Eckhardt C, Kiefel V (Hrsg) (2004) Transfusionsmedizin: Grundlagen – Therapie – Methodik. 3. Aufl. Springer-Verlag, Berlin Heidelberg New York
Eckstein R (2005) Immunhämatologie und Transfusionsmedizin. 5. Aufl. Gustav Fischer, Stuttgart
Bundesärztekammer (2005) Richtlinien zur Gewinnung von Blut und Blutbestandteilen und zur Anwendung von Blutprodukten (Hämotherapie). Aufgestellt gemäß Transfusionsgesetz von der Bundesärztekammer im Einvernehmen mit dem Paul-Ehrlich-Institut, Gesamtnovelle 2005, Deutscher Ärzteverlag, Köln
Lehman DC (2007) Biochemical Identification of Gram- Negative Bacteria. In: Mahon CR, Lehman DC, Manuselis G (eds) Textbook of Diagnostic Microbiology. 3. Aufl. Saunders Elsevier, pp 226–232
Kingston HM, Kingston ML (1994) Nomenclature in laboratory robotics and automation. IUPAC recommendations 1994. Pure & Appl Chem 66:609–630
Haeckel R et al (1995) Rationalisierung quantitativer Analysenverfahren. In: Greiling H, Gressner AM (Hrsg) Lehrbuch der Klinischen Chemie und Pathobiochemie. 3. Aufl. Schattauer Verlag, Stuttgart New York
Brown TA (Hrsg) Moderne Genetik. 2. Aufl. Spektrum Akademischer Verlag, Heidelberg-Berlin, S 19
Berzowsky JA, Epstein SL, Berkower IJ (1989) Antigen-antibody interactions and monoclonal antibodies. In: Paul WE (ed) Fundamental Immunology. 2nd edn. Raven Press, New York, S 315–356
Klein J (1990) Antigen-antibody interactions. In: Klein J, Horejsi V (eds)Immunology. Blackwell Scientific, Cambridge MA, S 294–310
Kaufmann SHE (2004) Antikörper und ihre Antigene. In Hahn H, Falke D, Kaufmann SHE, Ullmann U (Hrsg) Medizinische Mikrobiologie und Infektiologie, 5. Aufl. Springer-Verlag, Heidelberg Berlin New York, S 61–77
Levett PN, Sonnenberg K, Sidaway F, Shead S, Niedrig M, Steinhagen K, Horsman GB, Drebot MA (2005) Use of IgG avidity assays for differentiation of primary from previous infections with West Nile virus. J Clin Microbiol 43:5873–5875
Chan KH, Sonnenberg K, Niedrig M, Lam SY, Pang CM, Chan KM, Ma SK, Seto WH, Peiris JSM (2007) Use of antibody avidity assays for diagnosis of severe acute respiratory syndrome coronavirus infection. Clin Vaccine Immunol 14:1433–1436
Simoni M, Bakker E, Krausz C (2004) EAA/EMQN Best Practice Guidelines for Molecular Diagnosis of Y-Chromosomal Microdeletions. State of the Art 2004. Int J Androl 27:240–249
Raicu F, Popa L, Apostol P et al (2003) Screening for Microdeletions in Human Y Chromosome – AZF Candidate Genes and Male Infertility. J Cell Mol Med 7:43–48
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Gressner, A., Arndt, T. (2013). A. In: Gressner, A., Arndt, T. (eds) Lexikon der Medizinischen Laboratoriumsdiagnostik. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-12921-6_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-12921-6_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-12920-9
Online ISBN: 978-3-642-12921-6
eBook Packages: Life Science and Basic Disciplines (German Language)